Search this site

Exec Summary: Corporate venture capital (CVC) plays an increasingly significant role in the healthtech industry, providing funding, expertise, and strategic partnerships to innovative startups. As healthcare giants and technology companies recognize the transformative potential of healthtech, they are actively investing in these ventures, shaping the future of healthcare delivery and innovation. Motivations for Corporate Venture Capital in Healthtech Several factors drive the growing involvement of CVC in the healthtech sector: Strategic Innovation: Healthtech startups offer a fertile ground for healthcare companies to explore new technologies, business models, and solutions to unmet medical needs. CVC investments provide access to cutting-edge innovations and potential future partners. Market Expansion: CVC can help healthcare companies expand into new markets and patient segments. By investing in healthtech startups, they can gain access to new technologies, expertise, and customer bases. Competitive Landscape: In an increasingly competitive healthcare landscape, CVC investments allow companies to stay ahead of the curve and maintain a leading position in the market. Financial Returns: CVC investments in healthtech startups can generate attractive financial returns, as the healthtech sector holds immense growth potential. Benefits of Corporate Venture Capital for Healthtech Startups Healthtech startups can reap numerous benefits from partnering with CVC firms, including: Funding: CVC investments provide crucial funding to support the development and growth of healthtech startups. Strategic Expertise: CVC firms offer valuable expertise in healthcare, business development, and regulatory matters, guiding startups through complex challenges. Market Access: CVC firms can connect startups with their extensive networks of healthcare providers, payers, and partners, facilitating market access and partnerships. Validation and Credibility: CVC investments provide validation and credibility to healthtech startups, enhancing their reputation and attracting further investment. Examples of Corporate Venture Capital in Healthtech Numerous notable examples highlight the active involvement of CVC in the healthtech sector: Johnson & Johnson Innovation: Through its CVC arm, Johnson & Johnson has invested in over 200 healthtech startups, focusing on areas such as digital health, medical devices, and biotechnology. Google Ventures: Google Ventures has invested in several promising healthtech startups, including Verily Life Sciences, 23andMe, and Flatiron Health, demonstrating its commitment to healthcare innovation. GE Ventures: GE Ventures has a strong track record of investing in healthtech startups, including Castlight Health, Evidation Health, and Pear Therapeutics, focusing on areas such as data analytics, precision medicine, and digital therapeutics. Merck Ventures: Merck Ventures has invested in a range of healthtech startups, including Clue, GlycoMimetics, and AbCellera, demonstrating its interest in areas such as women's health, oncology, and immunotherapy. Samsung Ventures: Samsung Ventures has invested in several healthtech startups, including Lyra Health, Pear Therapeutics, and 2Morrow, focusing on areas such as mental health, digital therapeutics, and personalized medicine. These examples illustrate the diverse range of CVC investments in healthtech, encompassing a wide spectrum of technologies and therapeutic areas. Future of Corporate Venture Capital in Healthtech CVC is expected to continue playing a prominent role in the healthtech industry, driven by the increasing importance of innovation and the growing potential of healthtech to transform healthcare delivery. CVC firms will continue to seek out promising startups, providing them with the funding, expertise, and strategic partnerships needed to succeed. As the healthtech sector matures, CVC investments are likely to focus on areas such as artificial intelligence, machine learning, data analytics, and personalised medicine, shaping the future of healthcare. Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://www.healthcare.digital HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk Corporate Venture Capital well-suited to investing in HealthTech companies Corporate venture capital (CVC) has been playing an increasingly important role in the HealthTech industry in recent years. This is due to a number of factors, including: The growing maturity of the HealthTech market: The HealthTech industry has become increasingly attractive to investors, as the market has matured and demonstrated strong growth potential. This has made CVCs more interested in investing in HealthTech companies, as they believe that these companies have a higher likelihood of success. The need for corporate innovation: Many large companies are looking to HealthTech for new sources of innovation. CVCs can help these companies to identify and invest in promising HealthTech startups, which can then provide their parent companies with access to new technologies and markets. The need for faster innovation cycles: The speed of innovation in the HealthTech industry is accelerating, and CVCs can help companies to move more quickly from idea to market. This is because CVCs have access to a network of experts and resources that can help companies to overcome the challenges of developing and commercializing new technologies. As a result of these factors, CVC funding for HealthTech companies has been growing rapidly in recent years. According to PitchBook, CVC investment in HealthTech reached $7.7 billion in 2020, up from $2.7 billion in 2015. There are a number of reasons why CVCs are particularly well-suited to investing in HealthTech companies. CVCs have a number of advantages over traditional venture capitalists, including: Deep industry knowledge: CVCs are often affiliated with large companies that have deep experience in the healthcare industry. This gives them a better understanding of the needs and challenges of healthcare providers and patients. Access to markets and distribution channels: CVCs have access to the markets and distribution channels of their parent companies. This can help HealthTech startups to get their products into the hands of patients more quickly and easily. Mentorship and support: CVCs can provide HealthTech startups with mentorship and support from experienced executives and industry experts. This can help companies to overcome challenges and grow their businesses more effectively. As a result of these advantages, CVCs are playing an increasingly important role in the development of new HealthTech solutions. They are helping to bring innovative technologies to market that are improving the lives of patients and making healthcare more affordable and accessible. Corporate Venture Capital success in HealthTech Corporate venture capital (CVC) has played a significant role in the growth and success of many HealthTech companies. CVCs bring a unique set of advantages to the table, including deep industry knowledge, access to markets and distribution channels, and mentorship and support from experienced executives and industry experts. These advantages have helped CVC-backed HealthTech startups to achieve significant success, as evidenced by numerous notable exits and acquisitions. Examples of CVC success in HealthTech: Denali Therapeutics: Founded in 2014, Denali Therapeutics is a clinical-stage biotechnology company developing novel therapies for neurodegenerative diseases. The company has raised over $1.3 billion in funding, including investments from CVCs such as Johnson & Johnson Innovation (JJI) and Amgen Ventures. In 2022, Denali Therapeutics partnered with Pfizer to develop a potential treatment for Alzheimer's disease. Omada Health: Founded in 2012, Omada Health is a digital health company that provides personalised weight management programs for adults. The company has raised over $400 million in funding, including investments from CVCs such as McKesson Ventures and Kaiser Permanente Ventures. In 2021, Omada Health was acquired by UnitedHealth Group for $5 billion. Oscar Health: Founded in 2012, Oscar Health is an online health insurance marketplace that provides personalised coverage and support to its members. The company has raised over $4 billion in funding, including investments from CVCs such as Google Ventures and General Atlantic. In 2022, Oscar Health went public on the Nasdaq stock exchange. Grail: Founded in 2015, Grail is a biotechnology company developing a non-invasive blood test for early-stage cancer detection. The company has raised over $2.5 billion in funding, including investments from CVCs such as Johnson & Johnson Innovation and Illumina Ventures. In 2022, Grail was acquired by Illumina for $8 billion. These are just a few examples of the many CVC-backed HealthTech companies that have achieved significant success. CVCs continue to play a vital role in driving innovation and improving patient care in the HealthTech industry. Factors contributing to CVC success in HealthTech: Deep industry knowledge: CVCs are often affiliated with large companies that have deep experience in the healthcare industry. This gives them a better understanding of the needs and challenges of healthcare providers and patients. Access to markets and distribution channels: CVCs have access to the markets and distribution channels of their parent companies. This can help HealthTech startups to get their products into the hands of patients more quickly and easily. Mentorship and support: CVCs can provide HealthTech startups with mentorship and support from experienced executives and industry experts. This can help companies to overcome challenges and grow their businesses more effectively. Long-term investment horizon: CVCs are often willing to invest in HealthTech companies with longer-term timelines for success. This is because they are aligned with the long-term growth strategies of their parent companies. Future of Corporate Venture Capital in HealthTech The future of corporate venture capital (CVC) in HealthTech is bright. CVCs are well-positioned to continue playing a significant role in driving innovation and improving patient care in the HealthTech industry. Here are some of the key trends that are shaping the future of CVC in HealthTech: Increased focus on early-stage investments: CVCs are increasingly investing in early-stage HealthTech companies, as they believe that these companies have the most potential for disruption and growth. This is a departure from the traditional CVC model, which has been more focused on later-stage investments. Greater collaboration with traditional venture capitalists (VCs): CVCs are increasingly collaborating with traditional VCs to invest in HealthTech companies. This is a strategic move, as it allows CVCs to tap into the expertise and network of VCs while still maintaining control over their investments. Emphasis on value creation: CVCs are placing a greater emphasis on value creation, as they are under increasing pressure to demonstrate the return on their investments. This means that CVCs are focusing on investments that have the potential to generate significant revenue for their parent companies. Investment in digital health and artificial intelligence (AI): CVCs are showing a strong interest in investing in digital health and AI startups. These technologies have the potential to revolutionize the healthcare industry, and CVCs are well-positioned to identify and invest in promising companies in these areas. Overall, the future of CVC in HealthTech is promising. CVCs have a unique set of advantages that make them well-suited to investing in HealthTech companies. As the industry continues to grow and evolve, CVCs are likely to play an even more important role in driving innovation and improving patient care. Here are some specific areas where CVCs are likely to focus in the future of HealthTech: Preventive care and chronic disease management: CVCs are interested in investing in companies that are developing innovative solutions for preventing and managing chronic diseases, such as diabetes, heart disease, and cancer. Personalised medicine: CVCs are interested in investing in companies that are developing personalised medicine solutions, such as gene therapy and precision medicine. Mental health and behavioural health: CVCs are interested in investing in companies that are developing innovative solutions for mental health and behavioural health disorders. AI and machine learning (ML) in healthcare: CVCs are interested in investing in companies that are using AI and ML to improve healthcare delivery, such as clinical decision support systems and predictive analytics. As these areas continue to develop, CVCs are likely to play a key role in driving innovation and improving patient care. They have the resources, expertise, and network to identify and invest in promising companies that are developing the next generation of HealthTech solutions. Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://www.healthcare.digital HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk

Exec Summary: Digital health direct-to-consumer (DTC) refers to healthcare products and services delivered directly to consumers online, bypassing traditional intermediaries like doctors or hospitals. It leverages technology to provide convenient and accessible healthcare solutions. To answer the question, yes digital health direct-to-consumer (DTC) has a future, but it's likely to look different than it does today. Let's have a deeper look as to why: Strong Growth Potential: Consumer Demand: People are increasingly interested in convenient and accessible healthcare solutions. DTC appeals to this desire with features like telehealth appointments and at-home services. Market Growth: The global healthcare e-commerce market is booming, expected to reach over $600 billion by 2026 Evolution, Not Disappearance: Shifting Focus: The industry might see a move towards B2B2C models, where DTC companies partner with healthcare providers or insurers to offer services to consumers. Addressing Challenges: Successful companies will need to navigate regulatory hurdles, build trust around data privacy, and offer clear value propositions for consumers who may be hesitant to pay out-of-pocket. Areas of Opportunity: Focus on Specific Needs: Companies that cater to specific health needs, like mental health or women's health (FemTech), might have an advantage. Integration with Traditional Care: DTC solutions that integrate seamlessly with traditional healthcare systems could be attractive to both patients and providers. Overall, the future of DTC in digital health is promising, but it requires adaptation and addressing current limitations. Companies that can provide valuable and convenient services within a complex healthcare landscape will likely thrive. Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://www.healthcare.digital HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk History of Digital Health DTC The history of digital health DTC (direct-to-consumer) can be traced back a few decades, with key advancements and growing popularity in recent years. Here's a timeline of some milestones: Early Days (1980s-1990s): Mail-Order Medical Supplies: The concept of DTC healthcare existed in a limited way with mail-order catalogs offering basic medical supplies and self-help books. Rise of Telehealth: Early forms of telehealth emerged, with some experimentation in using telephones and video conferencing for remote consultations. Growth and Innovation (2000s-2010s): E-commerce Boom: The rise of e-commerce platforms like Amazon opened doors for selling health and wellness products directly to consumers. Rise of DTC Pharmacies: Online pharmacies offering prescription medications with online consultations began appearing. Mobile Health (mHealth) Revolution: The widespread adoption of smartphones led to a surge in mHealth apps for fitness tracking, symptom management, and medication reminders. Direct-to-Consumer Genetic Testing: Companies started offering genetic testing kits directly to consumers, raising questions about data privacy and the interpretation of genetic information. Recent Developments (2020s): COVID-19 Pandemic: The pandemic accelerated the use of telehealth and DTC services as people sought remote healthcare options. Increased Investment: Investment in the DTC healthcare space has boomed, with venture capitalists recognising its potential Regulatory Scrutiny: Regulatory bodies are increasingly scrutinising DTC practices, focusing on data privacy and the potential for misleading advertising. Shifting Landscape: The industry is seeing a trend towards B2B2C models, where DTC companies partner with healthcare providers or insurers to offer services. The Future: The future of DTC digital health is uncertain but holds promise. The industry will likely continue to evolve, addressing challenges like regulatory hurdles and consumer trust. Companies that can provide valuable and convenient services within a complex healthcare landscape are likely to be the ones that succeed. What exactly is digital health direct-to-consumer? Digital health direct-to-consumer (DTC) refers to healthcare products and services delivered directly to consumers online, bypassing traditional intermediaries like doctors or hospitals. It leverages technology to provide convenient and accessible healthcare solutions. The range of DTC offerings is vast and constantly evolving. Examples include: Telehealth consultations: Virtual doctor visits for diagnosis, treatment, and prescription refills. Mental health services: Online therapy sessions, meditation apps, and mental health chatbots. DTC medication delivery: Online pharmacies offering prescription medications with online consultations. Wearable devices and health trackers: Devices that monitor health data like heart rate, sleep patterns, and activity levels. Personalised health information: Websites and apps offering health information tailored to individual needs. At-home testing kits: Kits for conditions like allergies, sexually transmitted infections (STIs), or even basic genetic testing. Overall, digital health DTC is a growing sector with the potential to revolutionise healthcare access and delivery. However, it's crucial to be aware of its limitations and use it responsibly alongside traditional healthcare services. Future of DTC Digital Health The future of DTC digital health is likely to be a mix of continuity and change. Here are some key trends to watch: Shifting Focus: B2B2C Model: We might see a rise in the B2B2C model, where DTC companies partner with healthcare providers or insurers to offer their services to consumers. This allows for better integration with traditional healthcare systems and potentially wider coverage for consumers. Focus on Specific Needs: Companies catering to specific health needs like mental health (mHealth), chronic disease management, or FemTech (women's health) are likely to find success. These areas have a high demand for convenient and personalised solutions. Addressing Challenges: Regulation: Companies will need to navigate evolving regulations around data privacy, advertising practices, and the licensing of telehealth services. Building Trust: Building trust with consumers around data security and the quality of information provided will be crucial. This might involve partnerships with established medical institutions or independent certifications. Value Proposition: DTC companies need to offer clear value propositions that justify their cost. This could be through convenience, affordability, personalised care plans, or integration with wearable devices and health data. Emerging Technologies: AI-powered Solutions: Artificial intelligence (AI) could play a bigger role in symptom analysis, personalised recommendations, and chatbots for initial consultations. Virtual Reality (VR) and Augmented Reality (AR): VR and AR could be used for therapeutic purposes like exposure therapy for phobias or rehabilitation exercises. Overall, the future of DTC digital health is likely to be: More Integrated: DTC solutions will likely integrate more seamlessly with traditional healthcare systems, creating a more holistic patient experience. Personalised: Companies will focus on offering personalised care plans and recommendations based on individual health data and needs. Data-Driven: Data analytics will play a major role in optimising DTC services, improving outcomes, and potentially reducing healthcare costs. The success of DTC digital health will depend on its ability to adapt to these changes, navigate the complex healthcare landscape, and provide genuine value to consumers. Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://www.healthcare.digital HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk

Exec Summary: Ultra-wideband (UWB) technology is a promising technology with a wide range of potential applications in medicine. Here are some of the most promising applications of UWB technology in medicine: Remote patient monitoring: UWB technology can be used to monitor patients' vital signs and activities remotely. This can be done by placing UWB sensors in the patient's home or other location. The sensors can then transmit data to a doctor or other healthcare provider, who can monitor the patient's health in real time. Fall detection: UWB technology can be used to detect falls in elderly people and people with disabilities. This can be done by placing UWB sensors in the patient's home or other location. If the sensor detects a fall, it can send an alert to a doctor or other healthcare provider. Localisation: UWB technology can be used to localize patients in hospitals and other healthcare settings. This can be done by placing UWB sensors in strategic locations. If a patient needs to be found quickly, the sensors can be used to track the patient's location. Surgery: UWB technology can be used to guide surgeons during surgery. This can be done by placing UWB sensors on the patient's body and on the surgical instruments. The sensors can then transmit data to a computer, which can be used to create a real-time 3D image of the patient's body. This image can be used by the surgeon to guide the surgical instruments. Medical imaging: UWB technology can be used to create images of the human body without the use of radiation. This can be done by using UWB waves to measure the reflections of objects in the body. This technology is still in its early stages of development, but it has the potential to revolutionise medical imaging. UWB technology is a promising technology with a wide range of potential applications in medicine. As the technology continues to develop, we can expect to see even more innovative applications of UWB in the healthcare industry. Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://www.healthcare.digital HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk Intro to Ultra-wideband (UWB) impulse radar: Ultra-wideband (UWB) impulse radar is a type of radar that uses short, high-power pulses of radio waves to measure the distance, velocity, and shape of objects. The UWB radar emits a short pulse of radio waves, which is reflected by the object and returns to the radar. The time it takes for the pulse to travel to the object and back is used to calculate the distance to the object. The frequency of the pulse is used to calculate the velocity of the object. UWB impulse radar has several advantages over traditional radar systems. First, it has a very high range resolution, which means that it can accurately measure the distance to objects that are close together. Second, it has a very high Doppler resolution, which means that it can accurately measure the velocity of objects that are moving quickly. Third, it is very resistant to interference from other radio signals. UWB impulse radar is used in a variety of applications, including: Automotive radar: UWB radar is used in cars to detect other cars, pedestrians, and obstacles. It is used for safety features such as blind spot monitoring, lane departure warning, and automatic emergency braking. Medical imaging: UWB radar is used to image the human body without radiation exposure. It is used to detect cancer, heart disease, and other diseases. Security: UWB radar is used to detect intrusions and track people and objects. It is used in airports, prisons, and other security-sensitive areas. Industrial automation: UWB radar is used to track the movement of objects in factories and warehouses. It is used for applications such as inventory management and quality control. UWB impulse radar is a promising technology with a wide range of applications. It is still under development, but it has the potential to revolutionize many industries. Here are some of the specific applications of UWB impulse radar: Through-wall imaging: UWB impulse radar can be used to image objects that are behind walls. This is because the radar's short pulses can penetrate walls and other obstacles. This makes UWB impulse radar ideal for applications such as search and rescue and homeland security. Vital sign monitoring: UWB impulse radar can be used to monitor a person's vital signs, such as heart rate and breathing. This is because the radar can detect the small changes in the body that are caused by these vital signs. UWB impulse radar can be used in hospitals and other healthcare settings to monitor patients. Object tracking: UWB impulse radar can be used to track the movement of objects. This is because the radar can measure the distance and velocity of objects. UWB impulse radar can be used in applications such as automated guided vehicles (AGVs) and robotics. Vehicle collision avoidance: UWB impulse radar can be used to detect other vehicles and objects in the vicinity of a vehicle. This information can be used to prevent collisions. UWB impulse radar is used in many modern vehicles as a safety feature. UWB impulse radar is a rapidly growing technology with a wide range of potential applications. It is still under development, but it has the potential to revolutionise many industries. Ultra-wideband (UWB) impulse radar and remote patient monitoring (RPM) Ultra-wideband (UWB) impulse radar can be used for remote patient monitoring (RPM) in a number of ways. Vital sign monitoring: UWB impulse radar can be used to monitor a person's vital signs, such as heart rate, breathing, and body temperature. This is because the radar can detect the small changes in the body that are caused by these vital signs. UWB impulse radar can be used in homes and other settings to monitor patients who are at risk for falls, heart attacks, or other health problems. Fall detection: UWB impulse radar can be used to detect falls. This is because the radar can detect the sudden change in acceleration that occurs when a person falls. UWB impulse radar can be used in homes and other settings to monitor elderly people and people with disabilities who are at risk for falls. Activity monitoring: UWB impulse radar can be used to monitor a person's activity levels. This is because the radar can detect the movement of the body. UWB impulse radar can be used in homes and other settings to monitor patients who are recovering from surgery or other medical conditions. Localization: UWB impulse radar can be used to localize a person's position. This is because the radar can measure the distance and angle to the person. UWB impulse radar can be used in homes and other settings to track the movement of patients who are at risk for wandering. UWB impulse radar is a promising technology for RPM. It is non-invasive, has a long range, and can be used to monitor a variety of vital signs and activities. However, UWB impulse radar is still under development, and there are some challenges that need to be addressed before it can be widely used for RPM. One challenge is that UWB impulse radar can be affected by noise and interference. This can make it difficult to accurately measure vital signs and activities. Another challenge is that UWB impulse radar can be expensive. This could limit its use in some settings. Despite these challenges, UWB impulse radar has the potential to revolutionize RPM. It could provide a more accurate and reliable way to monitor patients' health than traditional methods. This could lead to better outcomes for patients and lower healthcare costs. Here are some of the companies that are developing UWB impulse radar for RPM: Keenly Health: Keenly Health is developing a system that uses UWB impulse radar to monitor patients' vital signs and activities in their homes AuraSense: AuraSense is developing a system that uses UWB impulse radar to detect falls and other medical events. Mital: Mital is developing a system that uses UWB impulse radar to localize patients in hospitals and other healthcare settings. These are just a few of the companies that are developing UWB impulse radar for RPM. This is a rapidly growing area of research, and it is likely that we will see more and more companies developing this technology in the coming years. Final Thoughts: UWB technology has the potential to revolutionize healthcare. It could provide a more accurate and reliable way to monitor patients' health than traditional methods. This could lead to better outcomes for patients and lower healthcare costs. For these reasons, successful and well known venture capital firms are investing in UWB technology startups, the main investors to date have been: Intel Capital: Intel Capital is the venture capital arm of Intel Corporation. The firm invests in early-stage companies that are developing technologies that are relevant to Intel's business. Intel Capital has invested in several UWB technology startups, including Kontakt.io and NXP Semiconductors. Sequoia Capital: Sequoia Capital is a venture capital firm that has invested in some of the most successful technology companies in the world, including Apple, Google, and Cisco Systems. The firm has also invested in several UWB technology startups, including Applied Intent and Pozyx. NEA: NEA is a venture capital firm that invests in early-stage companies that are developing innovative technologies. The firm has invested in several UWB technology startups, including Decawave and Time Domain. Draper Fisher Jurvetson: Draper Fisher Jurvetson is a venture capital firm that has invested in a wide range of technology companies, including Tesla, SpaceX, and Spotify. The firm has also invested in several UWB technology startups, including UWB Sensor Systems and Ubisense. Khosla Ventures: Khosla Ventures is a venture capital firm that invests in early-stage companies that are developing disruptive technologies. The firm has invested in several UWB technology startups, including AirTag and Context.io. These are just a few of the venture capital firms that are investing in UWB technology startups. The UWB technology space is rapidly growing, and we can expect to see even more venture capital firms investing in this area in the coming years. Here are some of the reasons why venture capitalists are investing in UWB technology startups: The potential for disruption: UWB technology has the potential to disrupt several established industries, including retail, manufacturing, and healthcare. This makes UWB technology a very attractive investment for venture capitalists. The growing market: The market for UWB technology is growing rapidly. This is due to the increasing demand for accurate and reliable location-based services. The strong team: Many UWB technology startups have strong teams with experience in developing and commercializing innovative technologies. This makes these startups more attractive to venture capitalists. Overall, the UWB technology space is a very promising area for investment. Venture capitalists are investing in UWB technology startups because of the potential for disruption, the growing market, and the strong teams behind these startups. Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://www.healthcare.digital HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk

Executive Summary: Epic has continued to focus on its core business of developing and supporting electronic health record (EHR) software for healthcare organizations. The company has also made some strategic moves, such as investing in new technologies and expanding its international reach. Here are some of the things that Epic has done since Oracle bought Cerner: Invested in new technologies: Epic has invested in new technologies, such as artificial intelligence (AI) and machine learning, to improve its EHR software. The company has also invested in research and development to develop new features and functionality for its software. Expanded its international reach: Epic has expanded its international reach by opening new offices in Europe and Asia. The company has also signed new contracts with healthcare organizations in these regions. Focused on customer satisfaction: Epic has focused on customer satisfaction by providing training and support to its customers. The company has also launched a new customer satisfaction program to measure and improve the satisfaction of its customers. Overall, Epic has continued to grow and innovate since Oracle bought Cerner. The company is well-positioned to continue to be a leader in the healthcare IT industry. Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://www.healthcare.digital HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk Here are some additional details about Epic's recent activities: In 2022, Epic launched a new product called EpicCare Intelligence. EpicCare Intelligence is a cloud-based platform that uses AI and machine learning to help healthcare organizations improve the quality of care, reduce costs, and improve patient satisfaction. In 2023, Epic opened a new office in London, UK. The new office will help Epic expand its reach into the European market. Epic has also been working on a number of new features and functionality for its EHR software. These new features include: A new AI-powered clinical decision support tool that will help clinicians make better decisions about patient care. A new patient portal that will make it easier for patients to access their medical records and communicate with their healthcare providers. A new telehealth platform that will allow healthcare providers to provide care to patients remotely. Epic is committed to continuing to innovate and improve its EHR software. The company believes that its EHR software can help healthcare organizations improve the quality of care, reduce costs, and improve patient satisfaction. EpicCare Intelligence EpicCare Intelligence is a cloud-based platform that uses artificial intelligence (AI) and machine learning to help healthcare organizations improve the quality of care, reduce costs, and improve patient satisfaction. EpicCare Intelligence is a suite of tools and applications that can be used to: Identify patients at risk for adverse events Predict which patients are likely to benefit from certain treatments Personalise treatment plans for individual patients Improve the efficiency of healthcare workflows Improve communication between healthcare providers and patients Make it easier for patients to access their medical records EpicCare Intelligence is available to all Epic customers, regardless of their size or location. The platform is constantly being updated with new features and functionality. Here are some of the benefits of using EpicCare Intelligence: Improved quality of care: EpicCare Intelligence can help healthcare organizations identify patients at risk for adverse events and predict which patients are likely to benefit from certain treatments. This information can be used to improve the care that patients receive. Reduced costs: EpicCare Intelligence can help healthcare organizations improve the efficiency of their workflows and reduce the amount of time that healthcare providers spend on administrative tasks. This can lead to cost savings. Improved patient satisfaction: EpicCare Intelligence can make it easier for patients to access their medical records and communicate with their healthcare providers. This can lead to improved patient satisfaction. EpicCare Intelligence is a powerful tool that can help healthcare organizations improve the quality of care, reduce costs, and improve patient satisfaction. The platform is constantly being updated with new features and functionality, making it a valuable asset for any healthcare organization. Here are some of the key features of EpicCare Intelligence: Predictive analytics: EpicCare Intelligence uses predictive analytics to identify patients at risk for adverse events and predict which patients are likely to benefit from certain treatments. Personalised medicine: EpicCare Intelligence can be used to personalise treatment plans for individual patients. Workflow automation: EpicCare Intelligence can be used to automate healthcare workflows, which can lead to improved efficiency and reduced costs. Patient engagement: EpicCare Intelligence can make it easier for patients to access their medical records and communicate with their healthcare providers. EpicCare Intelligence is a valuable tool for any healthcare organization that is looking to improve the quality of care, reduce costs, and improve patient satisfaction. The platform is constantly being updated with new features and functionality, making it a valuable asset for any healthcare organization. New Patient Portal Epic Systems Corporation has announced a new patient portal that will allow patients to access their medical records, schedule appointments, and communicate with their healthcare providers. The new portal is called MyChart, and it is available to all Epic customers. MyChart is a web-based application that allows patients to: View their medical records, including test results, medications, and allergies. Schedule appointments with their healthcare providers. Communicate with their healthcare providers through secure messaging. View educational materials about their health conditions. Access their personal health information (PHI) from any device with an internet connection. MyChart is a secure application that uses encryption to protect patient data. Patients can access MyChart using a username and password, and they can also use two-factor authentication to add an extra layer of security. MyChart is a valuable tool for patients that can help them to stay healthy and manage their healthcare. The portal is easy to use and provides patients with access to their medical records, appointment scheduling, and communication with their healthcare providers. Here are some of the benefits of using MyChart: Improved patient engagement: MyChart can help patients to stay more engaged in their healthcare by giving them access to their medical records and the ability to communicate with their healthcare providers. Reduced costs: MyChart can help to reduce costs by reducing the number of phone calls and faxes that are made between patients and healthcare providers. Improved quality of care: MyChart can help to improve the quality of care by giving patients access to their medical records and the ability to communicate with their healthcare providers. MyChart is a valuable tool for both patients and healthcare providers. The portal can help to improve patient engagement, reduce costs, and improve the quality of care. Potential plans in 2024 Epic Systems Corporation is a private healthcare technology company headquartered in Verona, Wisconsin. The company has been in business for over 40 years and has over 20,000 employees. Epic is a leading provider of electronic health record (EHR) software and related services. In 2024, Epic is expected to continue to grow and innovate. The company is investing heavily in research and development, and is working on a number of new features and functionality for its EHR software. Epic is also expanding its international reach, and is opening new offices in Europe and Asia. Here are some of the key things that Epic is expected to do in 2024: Continue to invest in research and development: Epic is investing heavily in research and development, and is working on a number of new features and functionality for its EHR software. These new features and functionality are expected to improve the quality of care, reduce costs, and improve patient satisfaction. Expand its international reach: Epic is expanding its international reach, and is opening new offices in Europe and Asia. The company believes that there is a significant opportunity for growth in these markets. Move its EHR software to the cloud: Epic is moving its EHR software to the cloud. The company believes that the cloud will provide a number of benefits, including improved security, scalability, and flexibility. Focus on improving patient engagement: Epic is focused on improving patient engagement. The company believes that patients who are more engaged in their care are more likely to get better outcomes. Epic is a leading provider of EHR software, and it is well-positioned for continued growth in the years to come. The company is committed to innovation, international expansion, cloud computing, and patient engagement. These are all key areas that will shape the future of healthcare. Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://www.healthcare.digital HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk

Exec Summary: The digital MSK (musculoskeletal) market is on the rise in 2024. MSK digital health solutions have raised $223M so far this year, already nearly double that of 2023’s $125M. Since 2010, more than $38 Billion has been invested in companies offering MSK solutions, including mergers and acquisitions. 'For people with a range of musculoskeletal (MSK) conditions, many virtual solutions deliver clinically meaningful improvements in pain and function, according to a new independent evaluation from the Peterson Health Technology Institute (PHTI). Based on a rigorous, independent review of scientific literature, the evidence indicates that many of these solutions offer clinical benefits to patients that are comparable to in-person physical therapy (PT). These solutions also have the potential to improve access to therapy, reduce healthcare spending, and offer greater convenience compared to in-person PT.' Source: https://phti.org/announcement/new-analysis-virtual-msk-solutions-improve-health-outcomes-and-lower-costs/ Here's what we can glean from recent news and developments mid 2024: Market Growth: The market is expected to see a compound annual growth rate (CAGR) of 27.4% from 2021 to 2028, driven by factors like increased adoption of digital health solutions and a need for more accessible MSK care. IPO Potential: Companies in this space are likely targeting IPOs in 2025. This is based on a few reasons: Recent Funding Rounds: Companies like Sword Health just secured a large funding round in 2024, potentially indicating they are well-capitalised for the near future and might focus on internal growth before an IPO. Market Conditions: The digital health IPO market has been a bit stagnant recently. While 2021 saw a boom, some companies are waiting for a more stable market before going public. Potential Digital MSK IPO's in 2025 An example of a successful digital MSK IPO is Physitrack, which went public in 2021. It's likely that other companies will follow suit in the coming years. Overall, digital MSK is a promising area in healthcare technology, and 2025 could be a big year for IPOs in this space. So who could go public in the next 18 months? Hinge Health: Hinge Health is a digital health company that provides virtual physical therapy and pain management services. The company uses sensors and artificial intelligence to track patients' movements and provide real-time feedback. Sword Health: Sword Health is a digital health company that provides patients with access to physical therapy, pain management, and other services through a mobile app. The company uses sensors and artificial intelligence to track patients' movements and provide real-time feedback. What is Digital MSK? Digital MSK, or digital musculoskeletal (MSK) care, refers to the use of technology and digital tools to improve the diagnosis, treatment, and management of conditions affecting the musculoskeletal system, which includes bones, joints, muscles, and other connective tissues. Digital MSK solutions can include telemedicine consultations, remote monitoring of patient symptoms and progress, digital platforms for self-assessment and self-management, and virtual physical therapy and rehabilitation programs. These solutions aim to make MSK care more convenient, accessible, and cost-effective for patients, while also improving outcomes and reducing the need for in-person visits. Digital MSK has become increasingly popular in recent years, particularly as a result of the COVID-19 pandemic, which has led to a rise in remote healthcare services. The use of digital tools for MSK care is particularly relevant given the high prevalence of MSK conditions, which affect millions of people around the world and can have a significant impact on quality of life and healthcare costs. Digital MSK is commonly referred to as digital physical therapy, so what is DPT? Digital physical therapy refers to the use of technology and digital tools to provide physical therapy services remotely, without requiring in-person visits to a physical therapy clinic or office. Digital physical therapy solutions can include telehealth consultations, remote monitoring of patient symptoms and progress, and digital platforms for self-assessment and self-management. Digital physical therapy solutions may use a variety of technologies, such as video conferencing, mobile apps, wearable devices, and virtual reality. These tools enable physical therapists to provide personalized treatment plans and exercises, monitor patient progress, and offer support and guidance to patients remotely. Digital physical therapy has become increasingly popular in recent years due to its convenience, accessibility, and cost-effectiveness. It also allows physical therapists to reach a broader patient population and provide more frequent and consistent care. However, it's important to note that digital physical therapy may not be appropriate for all patients or conditions, and in-person physical therapy may still be necessary for some patients. Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://www.healthcare.digital HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk What is driving the Digital MSK market? The digital MSK market worldwide is growing rapidly, driven by factors such as the high prevalence of MSK conditions, the increasing adoption of digital health solutions, and the need for more accessible and cost-effective MSK care. According to a report by Grand View Research, the global digital MSK market size was valued at USD 2.98 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 27.4% from 2021 to 2028. The market is expected to be driven by a range of digital MSK solutions, including telemedicine, remote monitoring, digital platforms for self-management, and virtual rehabilitation programs. These solutions are being adopted by healthcare providers, employers, and insurers to provide more convenient, efficient, and accessible MSK care to patients. North America is currently the largest market for digital MSK solutions, with a high prevalence of MSK conditions and a strong healthcare IT infrastructure. However, the market is also expected to grow rapidly in other regions, such as Europe and Asia-Pacific, as digital health solutions become more widely adopted. How much investment has gone into digital MSK? Investment in digital MSK has grown significantly in recent years, reflecting the increasing demand for digital health solutions to address the growing prevalence of MSK conditions. According to a report by CB Insights, funding for digital MSK companies reached a record high of $1.6 billion in 2020, more than double the funding in 2019. Some of the largest funding rounds and strategic partnerships in digital MSK in recent years include: Sword Health, an AI-powered virtual physical therapy startup, has raised $30 million and let employees sell $100 million worth of equity to new and existing investors, including Khosla Ventures. The round brings the nine-year-old company’s valuation to $3 billion, a 50% increase from the $2 billion value it garnered in its Series D in November 2021. (https://techcrunch.com/2024/06/04/sword-healths-raises-130m-valuation-3b-ai-physical-therapy/?mc_cid=db8fb495ca&mc_eid=db909483f7) FIGUR8, the leading innovator in the measure of musculoskeletal (MSK) health, has successfully closed a $25 million Series A-1 funding. The round was led by First Spark Ventures (FSV) with participation from DigiTx Partners and Phoenix Venture Partners (https://www.businesswire.com/news/home/20230808454865/en/FIGUR8-the-market-leader-for-measuring-musculoskeletal-MSK-health-and-injury-recovery-secures-25M-Series-A-1-financing) Teladoc Health announced new strategic partnerships with musculoskeletal (MSK) care providers Sword Health & Hinge Health to offer employers access to a full suite of digital physical therapy solutions for joint and muscle pain relief. MSK conditions are a top cost driver for 76% of employers in the U.S. (second only to cancer), costing an estimated $213B in annual treatment, care and lost wages. The move helps Teladoc Health clients offer a broader range of virtual care services to their employees through simplified contracting and management. (https://hitconsultant.net/2023/10/09/teladoc-health-partners-with-sword-health-hinge-health/) What are the signs of Digital MSK's massive growth potential? A) Physitrack IPO European digital physical therapy and patient engagement company Physitrack went public on the Nasdaq First North Premier Growth Market in June 2021 with an original offering of SEK 40 ($4.69) per share. The company's IPO included just under 4.4 million newly issued shares worth approximately SEK 175 ($20 million). Founded in 2012, Physitrack works primarily with the employer market to offer digital physical therapy, telehealth and patient engagement tools. "The IPO of Physitrack is the next step in our growth journey to continue bringing our solution to even more healthcare providers and patients around the world," wrote Physitrack CEO and cofounder Henrik Molin in an email to MobiHealthNews. "The strong interest in the IPO is proof of the support we see among investors. We are pleased to have attracted strong institutional names among our new shareholders, as well as a diverse base of investors among the general public in Sweden and Finland." Source: https://www.physitrack.co.uk/press/digital-physical-therapy-company-physitrack-goes-public-in-20m-ipo B) Omada Health acquires Physera Physera was founded in 2015 and is headquartered in Omaha, Nebraska. The company's platform enables patients to access physical therapy from the comfort of their own homes, using a combination of wearable devices, telehealth consultations, and a mobile app. Physera has received several rounds of funding, including a $6 million Series A funding round in 2018 and a $15 million Series B funding round in 2020. In 2021, the company was acquired by Omada Health, a digital health company that offers a range of chronic disease management solutions, including diabetes prevention and management, hypertension management, and behavioral health. The acquisition of Physera by Omada Health is expected to expand Omada's offering to include virtual physical therapy, which can be integrated with its existing platform to provide a more comprehensive care experience for patients with musculoskeletal conditions. The acquisition also reflects the growing interest in digital health solutions for musculoskeletal care, as patients and healthcare providers seek more accessible, convenient, and cost-effective ways to manage these conditions. C) Digital Tools to release clinical pressure The digital MSK market is growing rapidly in Europe, driven by factors such as the increasing prevalence of musculoskeletal conditions, the need for more accessible and cost-effective care solutions, and the adoption of digital health technologies by healthcare providers. According to a report by McKinsey & Company, the European digital health market is expected to grow to €45 billion by 2025, with musculoskeletal conditions accounting for a significant share of this growth. The report also notes that virtual care solutions, including virtual physical therapy and remote monitoring, have the potential to reduce costs, improve patient outcomes, and increase access to care. D) Clinical benefits now supported with outcomes and evidence Digital MSK (Musculoskeletal) solutions offer several clinical benefits for patients and healthcare providers, including: Improved patient outcomes: Digital MSK solutions provide patients with access to personalized care plans, remote monitoring, and self-management tools that can help improve clinical outcomes, reduce pain and disability, and enhance overall quality of life. More efficient care delivery: Digital MSK solutions can help healthcare providers deliver care more efficiently, by reducing the need for in-person visits, streamlining communication between providers and patients, and automating administrative tasks. Better patient engagement: Digital MSK solutions can help patients stay engaged and motivated in their care by providing real-time feedback, personalised exercise plans, and social support through online communities. Increased access to care: Digital MSK solutions can help improve access to care for patients who may face geographic or financial barriers to traditional in-person care, particularly in rural or underserved areas. Enhanced data collection and analysis: Digital MSK solutions can collect and analyse large amounts of data on patient outcomes, treatment efficacy, and population health trends, enabling healthcare providers to make data-driven decisions and improve care delivery. Overall, digital MSK solutions offer a promising approach to improving musculoskeletal care, particularly for patients with chronic conditions such as osteoarthritis, back pain, and rheumatoid arthritis. By leveraging the latest technology, digital MSK solutions can help healthcare providers deliver more personalized, efficient, and effective care to patients, while reducing costs and improving outcomes. E) Cost savings for providers and payers Digital MSK (Musculoskeletal) solutions have the potential to generate significant cost savings for patients, healthcare providers, and payers. Some of the key ways in which digital MSK solutions can reduce costs include: Reduced healthcare utilisation: Digital MSK solutions can help reduce healthcare utilisation by providing patients with access to self-management tools, remote monitoring, and virtual consultations, which can reduce the need for in-person visits and hospitalisations. Lower medication costs: Digital MSK solutions can help reduce medication costs by providing patients with personalised exercise plans, self-management tools, and coaching, which can help reduce reliance on medications. Reduced absenteeism and presenteeism: Musculoskeletal conditions are a leading cause of absenteeism and presenteeism in the workplace. Digital MSK solutions can help reduce these costs by providing employees with access to virtual physical therapy, self-management tools, and ergonomic assessments, which can help prevent and manage MSK-related pain and disability. Improved clinical outcomes: Digital MSK solutions can help improve clinical outcomes and reduce the need for costly medical interventions such as surgery or long-term medication use. More efficient care delivery: Digital MSK solutions can help healthcare providers deliver care more efficiently, reducing the need for administrative tasks and streamlining communication with patients. Overall, the cost savings generated by digital MSK solutions can be significant, particularly for patients with chronic MSK conditions who require ongoing care and management. By providing more accessible, convenient, and cost-effective care, digital MSK solutions can help reduce the economic burden of MSK conditions for patients, healthcare providers, and payers. Four companies leading the Digital MSK revolution 1. Hinge Health Hinge Health is building the world’s most patient-centered Digital Musculoskeletal (MSK) Clinic™. It is now the leading Digital MSK Clinic, used by four in five employers and 90% of health plans with a digital MSK solution. Hinge Health reduces MSK pain, surgeries, and opioid use by pairing advanced wearable sensors and computer vision technology with a comprehensive clinical care team of physical therapists, physicians, and board-certified health coaches. Hinge Health’s HingeConnect integrates with 1 million + in-person providers and enables real-time interventions for elective MSK surgeries, driving proven medical claims reduction. Available to millions of members, Hinge Health is widely trusted by leading organizations, including Land O’Lakes, L.L. Bean, Salesforce, Self-Insured Schools of California, Southern Company, State of New Jersey, US Foods, and Verizon. 2. Kaia Health Kaia Health is the world’s largest digital therapeutics company on a mission to empower millions of people to live their healthiest lives. Our evidence-based treatments, covering a range of conditions, including musculoskeletal pain and COPD, are powered by proprietary motion analysis technology and clinical expertise. No sensors or wearables are required, Kaia’s programs need only a smartphone to deliver the most accessible, effective, and equitable experience for all. Eleven clinical trials have shown Kaia’s effectiveness and safety to be as good as traditional care with up to 80% reduction in cost. Kaia Health is a member of the Digital Therapeutics Alliance (DTA) and is headquartered in NY and Munich. Kaia partners with leading health plans, employers, and providers, covering 60+ million lives around the world. 3. getUbetter getUbetter is the UK's market leading 'Digital MSK Self Care Platform' and 'NHSx MSK Digital Playbook' Case Study partnering with 17 Integrated Care Systems across England totalling over 40% market share. getUbetter provides 24/7 self-management support, so people trust their recovery and are only re-directed to healthcare services when necessary. getUbetter won the highly prestigious "HealthTech Partnership of the Yar Award at the HSJ Partnership Awards 2023" for their work with South West London ICS. We are providing NHS organisations and clinicians with new ways to support people with common MSK conditions via end to end digital injury support and condition management. Our cost efficient, evidence-based technology is simple to integrate across the whole care system. It is a new way to provide recovery, prevention and support to every person that needs it. Helping them before, during and after any contact with their local service. MSK pathways have had to adapt rapidly due to Covid-19 and we have been able to support our NHS partners to provide a digitally enabled MSK pathways, support self-management whilst safety netting alongside the ability to change these pathways rapidly to meet changing demands and services. 4. Sword Health Sword Health is on a mission to free two billion people from pain as the first and only end-to-end platform to prevent, manage, and treat pain while saving clients millions in healthcare costs. Sword combines proprietary artificial intelligence with rigorous clinical expertise to achieve a 60% reduction in surgery intent and an engagement rate of 3x traditional physical therapy. Today, Sword is the leading patent-holder in digital solutions addressing physical pain and serves more than 1,300 employers and health plans across three continents, including many Fortune 500 companies. With more than $300 million raised from top venture firms like Bond, Founders Fund, General Catalyst, Khosla Ventures, and Sapphire Ventures, and a $2 billion valuation, Sword was recently recognized as a Forbes Best Startup Employer, and has become the fastest-growing company in the category since its founding in 2015. Sword Health has offices in New York City, Chicago, Atlanta, Salt Lake City, Sydney and Porto. Factors driving the adoption of MSK solutions: There are several factors driving the adoption of digital MSK solutions: Increased prevalence of MSK conditions: MSK conditions, such as arthritis, back pain, and osteoporosis, are very common and affect millions of people worldwide. The growing prevalence of these conditions is increasing demand for MSK care, and digital solutions are seen as a way to expand access to care and improve outcomes. Need for more accessible and convenient care: Many patients face barriers to accessing traditional in-person MSK care, such as long wait times, transportation issues, and high costs. Digital MSK solutions, such as telemedicine and remote monitoring, offer more convenient and accessible options for patients to receive care. Advances in technology: The development of new technologies, such as wearable devices, telemedicine platforms, and mobile apps, has made it easier to deliver MSK care remotely and monitor patient progress more effectively. Changing healthcare landscape: There is a growing focus on value-based care and improving patient outcomes, which has led to increased interest in digital health solutions that can improve care delivery and patient engagement. COVID-19 pandemic: The COVID-19 pandemic has accelerated the adoption of digital MSK solutions, as many patients have been unable or unwilling to access in-person care. The pandemic has highlighted the need for more flexible and resilient healthcare systems that can adapt to changing circumstances. Overall, the adoption of digital MSK solutions is expected to continue to grow as healthcare providers, payers, and patients seek more accessible, convenient, and effective ways to manage MSK conditions. Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://www.healthcare.digital HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk

What is Digital MSK? Digital MSK, or digital musculoskeletal (MSK) care, refers to the use of technology and digital tools to improve the diagnosis, treatment, and management of conditions affecting the musculoskeletal system, which includes bones, joints, muscles, and other connective tissues. Digital MSK solutions can include telemedicine consultations, remote monitoring of patient symptoms and progress, digital platforms for self-assessment and self-management, and virtual physical therapy and rehabilitation programs. These solutions aim to make MSK care more convenient, accessible, and cost-effective for patients, while also improving outcomes and reducing the need for in-person visits. Digital MSK has become increasingly popular in recent years, particularly as a result of the COVID-19 pandemic, which has led to a rise in remote healthcare services. The use of digital tools for MSK care is particularly relevant given the high prevalence of MSK conditions, which affect millions of people around the world and can have a significant impact on quality of life and healthcare costs. Digital MSK is commonly referred to as digital physical therapy, so what is DPT? Digital physical therapy refers to the use of technology and digital tools to provide physical therapy services remotely, without requiring in-person visits to a physical therapy clinic or office. Digital physical therapy solutions can include telehealth consultations, remote monitoring of patient symptoms and progress, and digital platforms for self-assessment and self-management. Digital physical therapy solutions may use a variety of technologies, such as video conferencing, mobile apps, wearable devices, and virtual reality. These tools enable physical therapists to provide personalized treatment plans and exercises, monitor patient progress, and offer support and guidance to patients remotely. Digital physical therapy has become increasingly popular in recent years due to its convenience, accessibility, and cost-effectiveness. It also allows physical therapists to reach a broader patient population and provide more frequent and consistent care. However, it's important to note that digital physical therapy may not be appropriate for all patients or conditions, and in-person physical therapy may still be necessary for some patients. Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://www.healthcare.digital HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk What is driving the Digital MSK market? The digital MSK market worldwide is growing rapidly, driven by factors such as the high prevalence of MSK conditions, the increasing adoption of digital health solutions, and the need for more accessible and cost-effective MSK care. According to a report by Grand View Research, the global digital MSK market size was valued at USD 2.98 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 27.4% from 2021 to 2028. The market is expected to be driven by a range of digital MSK solutions, including telemedicine, remote monitoring, digital platforms for self-management, and virtual rehabilitation programs. These solutions are being adopted by healthcare providers, employers, and insurers to provide more convenient, efficient, and accessible MSK care to patients. North America is currently the largest market for digital MSK solutions, with a high prevalence of MSK conditions and a strong healthcare IT infrastructure. However, the market is also expected to grow rapidly in other regions, such as Europe and Asia-Pacific, as digital health solutions become more widely adopted. How much investment has gone into digital MSK? Investment in digital MSK has grown significantly in recent years, reflecting the increasing demand for digital health solutions to address the growing prevalence of MSK conditions. According to a report by CB Insights, funding for digital MSK companies reached a record high of $1.6 billion in 2020, more than double the funding in 2019. Some of the largest deals in digital MSK in recent years include: Hinge Health, a digital MSK company that provides virtual physical therapy and coaching, raised $310 million in a Series D funding round in 2021. Kaia Health, a digital MSK company that offers an app-based platform for self-management and virtual physical therapy, raised $75 million in a Series C funding round in 2020. Sword Health, a digital MSK company that provides virtual physical therapy, raised $25 million in a Series B funding round in 2020. Physera, a digital MSK company that provides virtual physical therapy and remote monitoring, was acquired by Omada Health for an undisclosed sum in 2021. Other digital MSK companies that have received significant investment include Hims & Hers, K Health, and Biofourmis. Overall, the significant investment in digital MSK reflects the growing recognition of the potential for digital health solutions to improve access to care and outcomes for patients with MSK conditions. What are the signs of Digital MSK's massive growth potential? A) Physitrack IPO European digital physical therapy and patient engagement company Physitrack went public on the Nasdaq First North Premier Growth Market in June 2021 with an original offering of SEK 40 ($4.69) per share. The company's IPO included just under 4.4 million newly issued shares worth approximately SEK 175 ($20 million). Founded in 2012, Physitrack works primarily with the employer market to offer digital physical therapy, telehealth and patient engagement tools. "The IPO of Physitrack is the next step in our growth journey to continue bringing our solution to even more healthcare providers and patients around the world," wrote Physitrack CEO and cofounder Henrik Molin in an email to MobiHealthNews. "The strong interest in the IPO is proof of the support we see among investors. We are pleased to have attracted strong institutional names among our new shareholders, as well as a diverse base of investors among the general public in Sweden and Finland." Source: https://www.physitrack.co.uk/press/digital-physical-therapy-company-physitrack-goes-public-in-20m-ipo B) Omada Health acquires Physera Physera was founded in 2015 and is headquartered in Omaha, Nebraska. The company's platform enables patients to access physical therapy from the comfort of their own homes, using a combination of wearable devices, telehealth consultations, and a mobile app. Physera has received several rounds of funding, including a $6 million Series A funding round in 2018 and a $15 million Series B funding round in 2020. In 2021, the company was acquired by Omada Health, a digital health company that offers a range of chronic disease management solutions, including diabetes prevention and management, hypertension management, and behavioral health. The acquisition of Physera by Omada Health is expected to expand Omada's offering to include virtual physical therapy, which can be integrated with its existing platform to provide a more comprehensive care experience for patients with musculoskeletal conditions. The acquisition also reflects the growing interest in digital health solutions for musculoskeletal care, as patients and healthcare providers seek more accessible, convenient, and cost-effective ways to manage these conditions. C) Digital Tools to release clinical pressure The digital MSK market is growing rapidly in Europe, driven by factors such as the increasing prevalence of musculoskeletal conditions, the need for more accessible and cost-effective care solutions, and the adoption of digital health technologies by healthcare providers. According to a report by McKinsey & Company, the European digital health market is expected to grow to €45 billion by 2025, with musculoskeletal conditions accounting for a significant share of this growth. The report also notes that virtual care solutions, including virtual physical therapy and remote monitoring, have the potential to reduce costs, improve patient outcomes, and increase access to care. D) Clinical benefits now supported with outcomes and evidence Digital MSK (Musculoskeletal) solutions offer several clinical benefits for patients and healthcare providers, including: Improved patient outcomes: Digital MSK solutions provide patients with access to personalized care plans, remote monitoring, and self-management tools that can help improve clinical outcomes, reduce pain and disability, and enhance overall quality of life. More efficient care delivery: Digital MSK solutions can help healthcare providers deliver care more efficiently, by reducing the need for in-person visits, streamlining communication between providers and patients, and automating administrative tasks. Better patient engagement: Digital MSK solutions can help patients stay engaged and motivated in their care by providing real-time feedback, personalised exercise plans, and social support through online communities. Increased access to care: Digital MSK solutions can help improve access to care for patients who may face geographic or financial barriers to traditional in-person care, particularly in rural or underserved areas. Enhanced data collection and analysis: Digital MSK solutions can collect and analyse large amounts of data on patient outcomes, treatment efficacy, and population health trends, enabling healthcare providers to make data-driven decisions and improve care delivery. Overall, digital MSK solutions offer a promising approach to improving musculoskeletal care, particularly for patients with chronic conditions such as osteoarthritis, back pain, and rheumatoid arthritis. By leveraging the latest technology, digital MSK solutions can help healthcare providers deliver more personalized, efficient, and effective care to patients, while reducing costs and improving outcomes. E) Cost savings for providers and payers Digital MSK (Musculoskeletal) solutions have the potential to generate significant cost savings for patients, healthcare providers, and payers. Some of the key ways in which digital MSK solutions can reduce costs include: Reduced healthcare utilisation: Digital MSK solutions can help reduce healthcare utilisation by providing patients with access to self-management tools, remote monitoring, and virtual consultations, which can reduce the need for in-person visits and hospitalisations. Lower medication costs: Digital MSK solutions can help reduce medication costs by providing patients with personalised exercise plans, self-management tools, and coaching, which can help reduce reliance on medications. Reduced absenteeism and presenteeism: Musculoskeletal conditions are a leading cause of absenteeism and presenteeism in the workplace. Digital MSK solutions can help reduce these costs by providing employees with access to virtual physical therapy, self-management tools, and ergonomic assessments, which can help prevent and manage MSK-related pain and disability. Improved clinical outcomes: Digital MSK solutions can help improve clinical outcomes and reduce the need for costly medical interventions such as surgery or long-term medication use. More efficient care delivery: Digital MSK solutions can help healthcare providers deliver care more efficiently, reducing the need for administrative tasks and streamlining communication with patients. Overall, the cost savings generated by digital MSK solutions can be significant, particularly for patients with chronic MSK conditions who require ongoing care and management. By providing more accessible, convenient, and cost-effective care, digital MSK solutions can help reduce the economic burden of MSK conditions for patients, healthcare providers, and payers. Five companies leading the Digital MSK revolution 1. Hinge Health Hinge Health is building the world’s most patient-centered Digital Musculoskeletal (MSK) Clinic™. It is now the leading Digital MSK Clinic, used by four in five employers and 90% of health plans with a digital MSK solution. Hinge Health reduces MSK pain, surgeries, and opioid use by pairing advanced wearable sensors and computer vision technology with a comprehensive clinical care team of physical therapists, physicians, and board-certified health coaches. Hinge Health’s HingeConnect integrates with 1 million + in-person providers and enables real-time interventions for elective MSK surgeries, driving proven medical claims reduction. Available to millions of members, Hinge Health is widely trusted by leading organizations, including Land O’Lakes, L.L. Bean, Salesforce, Self-Insured Schools of California, Southern Company, State of New Jersey, US Foods, and Verizon. 2. Kaia Health Kaia Health is the world’s largest digital therapeutics company on a mission to empower millions of people to live their healthiest lives. Our evidence-based treatments, covering a range of conditions, including musculoskeletal pain and COPD, are powered by proprietary motion analysis technology and clinical expertise. No sensors or wearables are required, Kaia’s programs need only a smartphone to deliver the most accessible, effective, and equitable experience for all. Eleven clinical trials have shown Kaia’s effectiveness and safety to be as good as traditional care with up to 80% reduction in cost. Kaia Health is a member of the Digital Therapeutics Alliance (DTA) and is headquartered in NY and Munich. Kaia partners with leading health plans, employers, and providers, covering 60+ million lives around the world. 3. getUbetter getUbetter is the UK's market leading 'Digital MSK Self Care Platform' and 'NHSx MSK Digital Playbook' Case Study partnering with 17 Integrated Care Systems across England totalling over 40% market share. getUbetter provides 24/7 self-management support, so people trust their recovery and are only re-directed to healthcare services when necessary. getUbetter won the highly prestigious "HealthTech Partnership of the Yar Award at the HSJ Partnership Awards 2023" for their work with South West London ICS. We are providing NHS organisations and clinicians with new ways to support people with common MSK conditions via end to end digital injury support and condition management. Our cost efficient, evidence-based technology is simple to integrate across the whole care system. It is a new way to provide recovery, prevention and support to every person that needs it. Helping them before, during and after any contact with their local service. MSK pathways have had to adapt rapidly due to Covid-19 and we have been able to support our NHS partners to provide a digitally enabled MSK pathways, support self-management whilst safety netting alongside the ability to change these pathways rapidly to meet changing demands and services. 4. Sword Health Sword Health is on a mission to free two billion people from pain as the first and only end-to-end platform to prevent, manage, and treat pain while saving clients millions in healthcare costs. Sword combines proprietary artificial intelligence with rigorous clinical expertise to achieve a 60% reduction in surgery intent and an engagement rate of 3x traditional physical therapy. Today, Sword is the leading patent-holder in digital solutions addressing physical pain and serves more than 1,300 employers and health plans across three continents, including many Fortune 500 companies. With more than $300 million raised from top venture firms like Bond, Founders Fund, General Catalyst, Khosla Ventures, and Sapphire Ventures, and a $2 billion valuation, Sword was recently recognized as a Forbes Best Startup Employer, and has become the fastest-growing company in the category since its founding in 2015. Sword Health has offices in New York City, Chicago, Atlanta, Salt Lake City, Sydney and Porto. 5. Fern Health Available through employers and health plans, Fern Health’s digital pain platform, Fern, addresses the underlying causes of persistent pain, not just the symptoms. Guided programs deliver exercise therapy, interventions for sleep, nutrition, daily movement, and emotional health. Every member is supported through pain-focused 1:1 clinical coaching and pain neuroscience education to improve function, reduce pain, and avoid unnecessary healthcare costs. Fern Health is majority owned by German life science company Grünenthal International, with other minority investors. Source: https://www.mobihealthnews.com/news/digital-musculoskeletal-care-booming-where-does-market-go-here Summary: There are several factors driving the adoption of digital MSK solutions: Increased prevalence of MSK conditions: MSK conditions, such as arthritis, back pain, and osteoporosis, are very common and affect millions of people worldwide. The growing prevalence of these conditions is increasing demand for MSK care, and digital solutions are seen as a way to expand access to care and improve outcomes. Need for more accessible and convenient care: Many patients face barriers to accessing traditional in-person MSK care, such as long wait times, transportation issues, and high costs. Digital MSK solutions, such as telemedicine and remote monitoring, offer more convenient and accessible options for patients to receive care. Advances in technology: The development of new technologies, such as wearable devices, telemedicine platforms, and mobile apps, has made it easier to deliver MSK care remotely and monitor patient progress more effectively. Changing healthcare landscape: There is a growing focus on value-based care and improving patient outcomes, which has led to increased interest in digital health solutions that can improve care delivery and patient engagement. COVID-19 pandemic: The COVID-19 pandemic has accelerated the adoption of digital MSK solutions, as many patients have been unable or unwilling to access in-person care. The pandemic has highlighted the need for more flexible and resilient healthcare systems that can adapt to changing circumstances. Overall, the adoption of digital MSK solutions is expected to continue to grow as healthcare providers, payers, and patients seek more accessible, convenient, and effective ways to manage MSK conditions. Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://www.healthcare.digital HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk

Exec Summary Meta Llama 3 is a state-of-the-art large language model (LLM) created by Meta AI. It's known for being one of the most powerful and openly available LLMs currently available. Here are some of the key features of Meta Llama 3: Improved Performance: Meta Llama 3 uses a tokeniser with a vocabulary of 128K tokens, which encodes language more efficiently. This leads to substantially improved model performance compared to previous versions. Openly Available: Unlike some other LLMs, Meta Llama 3 is available for anyone to use. This makes it a valuable resource for researchers, developers, and businesses. Focus on Healthcare: Meta Llama 3 has been specifically optimised for use in healthcare and life sciences workflows. It can be used to develop applications that can improve patient care and outcomes. Easy Integration: Meta Llama 3 is available as a downloadable NVIDIA NIM inference microservice. This makes it easy to integrate into existing applications and workflows. Meta Llama 3 is making waves in the healthcare field, offering significant improvements through its capabilities. Here are some key areas where it's showing success: Clinical Research Acceleration: Companies like ConcertAI are leveraging Meta Llama 3 to streamline clinical trial processes. It facilitates patient matching, automates study tasks, and assists researchers with real-time insights. This significantly reduces research timelines and costs. Enhanced Clinical Insights: Mendel AI is another company utilizing Meta Llama 3 to unlock valuable insights from vast amounts of medical data. The model can decipher nuances in patient records, allowing for more informed clinical decisions and improved patient care. Real-World Evidence Generation: Meta Llama 3 is proving adept at analyzing real-world medical data to assess treatment effectiveness. This can lead to better understanding of medications and therapies outside of controlled trials. Improved Efficiency: By automating tasks like information extraction from patient records and translating natural language queries, Meta Llama 3 frees up valuable time for healthcare professionals. This allows them to focus on providing better patient care. Overall, Meta Llama 3 is a powerful tool that's transforming healthcare by accelerating research, improving clinical insights, and streamlining workflows. As research continues, we can expect to see even more innovative applications emerge in the future. Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://www.healthcare.digital HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk Introduction to Meta Llama 3 Meta Llama 3 is a game-changer in the world of large language models (LLMs). Developed by Meta AI, it boasts impressive capabilities and open accessibility, making it a powerful tool for various fields. Here's a quick introduction to pique your interest: Powerhouse Performance: Meta Llama 3 comes in two versions: 8 billion and 70 billion parameters. This massive size translates to exceptional performance in understanding and generating language. It tackles complex tasks with greater accuracy and efficiency compared to its predecessors. Open to All: Unlike many LLMs, Meta Llama 3 breaks down barriers by being openly available. This makes it a valuable resource for researchers, developers, and businesses of all sizes. Anyone with an interest in AI can explore its potential and contribute to its development. Versatility Beyond Text: While excelling in language processing, Meta Llama 3 isn't limited to text alone. It can handle multimodal inputs, meaning it can process images and videos alongside text. This opens doors for applications like generating video descriptions or creating multimedia presentations. Focus on Integration: Meta Llama 3 is designed for easy integration into existing workflows. It comes as a downloadable NVIDIA NIM inference microservice, making it readily deployable in various applications. Beyond the Basics: Meta Llama 3's impact extends beyond its core functionalities. Here are some exciting aspects to consider: Democratizing AI: Open access paves the way for broader participation in the AI revolution. Smaller companies and individual researchers can now access powerful tools previously limited to large corporations. The Future of Healthcare: Meta Llama 3 is making significant strides in healthcare. From accelerating clinical research to generating real-world evidence, it holds immense potential for improving patient care and outcomes. Image Source: https://llama.meta.com/llama3/ Advantages for Meta Llama 3 - Open Source Meta Llama 3 stands out for being an open source large language model (LLM). This openness contributes significantly to its potential and offers several advantages: Accessibility for All: Unlike some LLMs that are restricted or require hefty licensing fees, Meta Llama 3 is freely available. This makes it a valuable resource for a wider range of users, including researchers, developers, and businesses of all sizes. Even individual AI enthusiasts can experiment and contribute to its development. Collaboration and Innovation: Open source nature fosters collaboration within the AI community. Developers can build upon Meta Llama 3's foundation, customize it for specific needs, and share their modifications for further improvement. This fosters a more collaborative environment and accelerates innovation in the LLM field. Transparency and Trust: With open source code, users can inspect how Meta Llama 3 works and understand its underlying algorithms. This transparency builds trust and allows users to identify potential biases or limitations within the model. Democratising AI: Open access to Meta Llama 3 levels the playing field in AI development. Smaller companies and individual researchers now have the opportunity to work with powerful tools previously limited to large corporations with significant resources. This broader accessibility can lead to a more diverse and innovative AI landscape. Beyond the Advantages: It's important to remember that open source also comes with some considerations: Maintenance and Support: While the core model is freely available, users might need to invest resources in setting up, maintaining, and customising Meta Llama 3 for their specific needs. Security Concerns: Open source code can be vulnerable to potential security risks. Users need to be aware of these risks and take appropriate precautions when deploying Meta Llama 3. Overall, Meta Llama 3 being open source is a significant advantage that fosters collaboration, innovation, and accessibility in the field of AI. It empowers a wider range of users to leverage its capabilities and contribute to its future development. Image Source: https://llama.meta.com/llama3/ Future of Meta Llama 3 The future of Meta Llama 3 is bright, with its potential applications reaching far and wide. Here are some exciting possibilities on the horizon: Enhanced Capabilities: Larger and More Powerful Models: We can expect even larger versions of Meta Llama 3 with more parameters. This will translate to even better performance and the ability to tackle even more complex tasks. Improved Reasoning and Understanding: The model's ability to reason and understand complex concepts is likely to improve significantly. This could lead to applications in areas like education, where it can personalise learning experiences or answer complex student queries. Multilingual Mastery: Meta Llama 3's grasp of multiple languages is expected to become more comprehensive, allowing for seamless communication and information processing across different languages. Widespread Adoption: Integration Across Industries: Meta Llama 3's open-source nature and versatility will likely lead to its adoption across various industries. We can expect to see it in applications like scientific research, content creation, customer service chatbots, and software development. Revolutionising Workflows: Meta Llama 3 has the potential to streamline workflows in various fields. Imagine automating repetitive tasks, generating reports, or summarising complex documents in seconds. Democratisation of AI Tools: Open access will continue to empower smaller companies and individual developers to leverage powerful AI tools. This broader accessibility can lead to a more diverse and innovative AI landscape. Emerging Applications: Personalised Experiences: Meta Llama 3's ability to understand user preferences could lead to highly personalised experiences. Imagine applications that tailor news feeds, create personalized learning materials, or recommend products based on individual needs. Generative AI Revolution: Meta Llama 3's capabilities in generating different creative text formats, like poems, code, scripts, musical pieces, can further accelerate the generative AI revolution. Challenges and Considerations: Ethical Considerations: As with any powerful AI tool, ethical considerations like bias and misuse will need to be addressed. Continued research and development focused on fairness and responsible AI practices will be crucial. Explainability and Transparency: Understanding how Meta Llama 3 arrives at its outputs (especially in complex tasks) will be important. Efforts towards explainable AI will be needed to ensure trust and responsible use. Overall, Meta Llama 3 represents a significant leap forward in open-source large language models. Its future holds immense potential for innovation and positive impact across various sectors. As the technology matures and ethical considerations are addressed, Meta Llama 3 has the potential to reshape how we interact with information, create content, and approach problem-solving in the future. Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://www.healthcare.digital HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk

Exec Summary: The use of sound to manage pain is a relatively new area of research, but it shows promise as a safe, non-invasive, and drug-free treatment option. There are two main approaches being investigated: Auditory stimulation: This involves listening to specific sounds or music that can help to distract from pain signals or modulate pain perception. Neuromodulation with sound: This combines sound with other forms of stimulation, such as electrical stimulation, to target specific areas of the nervous system involved in pain processing. Studies have shown that auditory stimulation can be effective in reducing pain perception in both acute and chronic pain conditions. For example, one study found that listening to music during labor and delivery could help to reduce pain and anxiety in women. Neuromodulation with sound is a newer area of research, but early studies have shown promising results. For example, a recent study found that combining electrical stimulation of the spinal cord with broadband sound was effective in reducing pain in guinea pigs. More research is needed to determine the long-term efficacy and safety of sound-based pain management techniques. However, the initial results suggest that sound has the potential to be a valuable tool for managing pain. Sound has shown promise in managing pain, and here's a deeper dive into what researchers are exploring: Potential Mechanisms: Gate Control Theory: Sound may activate the body's natural pain-relieving system. The theory suggests that non-painful stimuli like sound can "close the gate" on pain signals traveling to the brain, reducing perceived pain intensity. Auditory Distraction: Specific soundscapes or music can distract the brain from focusing on pain signals. Focusing on an engaging sound can effectively reduce the perceived intensity of pain. Relaxation and Stress Reduction: Certain sound frequencies or calming melodies can promote relaxation and reduce stress hormones, which can indirectly contribute to pain perception. Research Directions: Identifying Effective Sounds: Researchers are investigating what types of sounds, frequencies, and music are most effective for different types of pain. This may involve personalized approaches based on individual preferences. Delivery Methods: Different methods of delivering sound for pain management are being explored. This could include headphones, speakers in treatment rooms, or even incorporating sound into mobile apps. Combining with Other Therapies: Studies are examining how sound therapy can be combined with other pain management techniques, like physical therapy or medication, to enhance their effectiveness. Examples of Existing Applications: Pre-operative and Post-operative Pain Management: Music therapy is being used in some hospitals to help manage pain before and after surgery. Chronic Pain Management: Sound therapy shows promise in managing chronic pain conditions like arthritis, headaches, and back pain. Overall, sound offers a safe, non-invasive approach to pain management, with the potential to reduce reliance on medication. While more research is needed, it's a promising area of HealthTech with exciting possibilities. Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://www.healthcare.digital HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk Gate Control Theory The Gate Control Theory of pain is a theory proposed in 1965 to explain how pain signals are transmitted to the brain and how we perceive pain. It suggests that the spinal cord acts like a gatekeeper for pain signals, determining whether they travel to the brain or not. Here's a breakdown of the theory: The Gate: The theory proposes a metaphorical "gate" located in the spinal cord. This gate controls the flow of pain signals from the periphery (like your skin) to the brain. Gatekeeper: Two types of nerve fibres influence this gate: small diameter fibres that transmit pain signals and large diameter fibres that transmit non-painful sensations like touch or pressure. Open Gate vs. Closed Gate: When the gate is open, pain signals are easily transmitted to the brain, resulting in a strong perception of pain. Conversely, when the gate is closed, fewer pain signals reach the brain, leading to a reduced perception of pain. The theory suggests that various factors can influence whether the gate is open or closed, including: Non-painful sensations: Strong non-painful sensations, like rubbing a sore muscle, can close the gate and reduce pain perception. Mental state: Stress, anxiety, and depression can open the gate and increase pain perception. Focus: Focusing on pain can keep the gate open, while distraction can close it. While the Gate Control Theory doesn't fully explain pain perception, it provides a helpful framework for understanding how various factors can influence our experience of pain. This knowledge is used in developing pain management strategies that target the "gate" to reduce pain perception. Neuromodulation Neuromodulation is a broad term for medical techniques that alter the activity of the nervous system. It essentially involves modulating or influencing nerve activity in specific areas to treat various conditions. Here's a breakdown of what neuromodulation entails: Targeting Nerves: Neuromodulation targets nerves directly using different methods like: Electrical stimulation: Electrodes are placed on the brain, spinal cord, or peripheral nerves to deliver controlled electrical pulses. Chemical agents: Tiny doses of specific drugs are delivered directly to the target area to influence nerve activity. Treatment Goals: The goal of neuromodulation can be to: Stimulate nerves: This can be done to activate neural pathways that might be underactive in conditions like Parkinson's disease. Inhibit nerves: This might be helpful in reducing pain signals or excessive neural activity in epilepsy. Applications: Due to its ability to target specific nerve activity, neuromodulation has a wide range of applications, including treating: Chronic pain: It can be used to manage pain from various conditions like neuropathic pain, back pain, and migraines. Movement disorders: Neuromodulation techniques are used to treat Parkinson's disease, essential tremor, and dystonia. Mental health conditions: Deep brain stimulation, a type of neuromodulation, is used in some cases of severe depression and obsessive-compulsive disorder (OCD). Here are some additional points to consider about neuromodulation: Types of Techniques: There are various neuromodulation techniques, each with its own approach and applications. Some common ones include deep brain stimulation (DBS), spinal cord stimulation (SCS), vagus nerve stimulation (VNS), and transcranial magnetic stimulation (TMS). Implantable vs. Non-invasive: Some neuromodulation techniques involve surgically implanted devices like DBS or SCS. Others, like TMS, are non-invasive and use external devices to stimulate the brain. Overall, neuromodulation offers a promising approach for treating various neurological and chronic pain conditions by directly influencing nerve activity. However, it's important to consult with a healthcare professional to determine if neuromodulation is a suitable treatment option for your specific condition. Auditory Distraction Auditory distraction is a technique used in pain management to divert your attention away from pain signals, potentially reducing your perception of pain. It's a non-invasive and drug-free approach that can be helpful for both acute and chronic pain. Here's how auditory distraction works in pain management: Competing Signals: When you focus on sounds other than the pain signals, it can "crowd out" the pain signals traveling to the brain. This can lead to a decreased perception of pain intensity. Gate Control Theory: Distraction may activate the body's natural pain-blocking mechanisms according to the Gate Control Theory. This theory proposes that the spinal cord acts like a gatekeeper for pain signals. When you focus on something else, it might figuratively "close the gate" and reduce the transmission of pain signals to the brain. Reduced Anxiety: Pain and anxiety often go hand-in-hand. Focusing on distracting sounds can help reduce anxiety, which can further decrease pain perception. Here are some examples of auditory distraction for pain management: Music: Listening to calming or upbeat music can be a powerful distraction. Choose music you find pleasant and relaxing, or that helps you focus on something else. Nature sounds: The calming sounds of nature, like waves crashing or birds chirping, can be very effective for distraction. Audiobooks or podcasts: Engaging with a captivating audiobook or podcast can pull your attention away from pain. Guided meditations: Meditations that incorporate calming sounds and focus techniques can be very effective for pain management. While research on auditory distraction for pain is ongoing, studies have shown promising results. For example, one study found that listening to music during labor and delivery could help to reduce pain and anxiety in women. Here are some things to consider when using auditory distraction for pain management: Individual preferences: What works for one person might not work for another. Experiment with different types of sounds to find what helps you manage pain best. Pain severity: Auditory distraction might be more effective for moderate pain than severe pain. Combine with other techniques: Auditory distraction can be used alongside other pain management techniques like relaxation techniques or medication for a more comprehensive approach. Future of Sound to Manage Pain The use of sound for pain management is a burgeoning field with exciting possibilities for the future. Here's a glimpse into some promising areas of exploration: Personalised Soundscapes: Research is moving towards creating personalised soundscapes tailored to individual preferences and pain responses. This could involve using biofeedback or brain imaging to identify the most effective sound frequencies or music genres for each person. Targeted Neuromodulation with Sound: Combining sound with other neuromodulation techniques like electrical stimulation shows promise. By carefully calibrating sound with electrical pulses, researchers hope to target specific neural pathways involved in pain perception, potentially offering more precise pain control. Virtual Reality (VR) with Integrated Soundscapes: VR technology is being explored to create immersive and distracting environments that incorporate soundscapes specifically designed to manage pain. Imagine undergoing a medical procedure while virtually exploring a calming underwater world with soothing sounds. Biofeedback with Auditory Cues: Biofeedback uses real-time physiological data to help people gain control over bodily functions. Integrating auditory cues with biofeedback could provide real-time feedback on relaxation levels, allowing individuals to adjust the soundscape for optimal pain management. Smartphone Apps for Auditory Analgesia: The development of smartphone apps loaded with various soundscapes and guided meditations could make sound-based pain management tools more accessible and user-friendly. Imagine having a personalised pain management toolbox readily available on your phone. Advanced Audio Engineering for Pain Management: Researchers are exploring how to use sound engineering principles to create specific sound frequencies or patterns that have a more potent analgesic (pain-relieving) effect. This could involve using specific rhythms, binaural beats (sounds that create a third beat when heard in each ear), or even ultrasonic frequencies. Focus on Mechanisms of Action: Understanding the precise mechanisms by which sound interacts with the nervous system to reduce pain is crucial. This will allow researchers to develop more targeted and effective sound-based pain management strategies. It's important to remember that this is a rapidly evolving field, and new discoveries are constantly being made. While more research is needed to solidify the efficacy of these approaches, the future of sound-based pain management holds immense potential for offering safe, non-invasive, and personalized pain relief options. Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://www.healthcare.digital HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk

Exec Summary: Apple has been making significant strides in the healthcare field, and their use of physics and light is a key part of their strategy. Here's a breakdown of how Apple leverages physics and light for a potential competitive advantage in healthcare: Light-based sensors: Apple devices like the Apple Watch use sensors that detect light in various ways. Photoplethysmography (PPG), for instance, uses light and photodiodes to measure heart rate by detecting blood volume changes in your wrist. Data collection and monitoring: These sensors collect a wealth of health data, allowing users to monitor their heart rate, sleep patterns, and even blood oxygen levels. This empowers individuals to take a more proactive approach to their health. Potential for treatment: While primarily focused on monitoring currently, there's a possibility of using light for treatment in the future. Conditions like psoriasis sometimes respond well to light therapy, and Apple could potentially explore similar applications. Overall, Apple's approach to healthcare with physics and light offers a two-pronged advantage: Enabling Care: By providing users with tools to monitor their health, Apple helps them take charge of their well-being. Delivering Care (potential): In the future, Apple's technology might extend to delivering light-based treatment options. However, it's important to note that this is a developing area for Apple. While they show promise, established healthcare providers still play a crucial role in diagnosis and treatment. Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://www.healthcare.digital HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk Apple Products Ambient light sensors, infrared light, LED lights, light‑sensitive photodiodes, spectroscopy, photoplethysmography, UV light, full spectrum light therapy, phototherapy .... Apple are applying light in new ways to create new standards, solve existing problems and make patients/consumers lives easier. 1) Apple Watch Heart Rate Monitor - Photoplethysmography The heart rate sensor in the Apple Watch uses what is known as photoplethysmography. This technology, while difficult to pronounce, is based on a very simple fact: Blood is red because it reflects red light and absorbs green light. Apple Watch uses green LED lights paired with light‑sensitive photodiodes to detect the amount of blood flowing through your wrist at any given moment. When your heart beats, the blood flow in your wrist — and the green light absorption — is greater. Between beats, it’s less. By flashing its LED lights hundreds of times per second, Apple Watch can calculate the number of times the heart beats each minute — your heart rate. The heart rate sensor supports a range of 30–210 beats per minute. In addition, the heart rate sensor is designed to compensate for low signal levels by increasing both LED brightness and sampling rate. The heart rate sensor can also use infrared light. This mode is what Apple Watch uses when it measures your heart rate in the background, and for elevated heart rate notifications. Apple Watch uses green LED lights to measure your heart rate during workouts and Breathe sessions, and to calculate walking average and Heart Rate Variability (HRV). 2) Apple Face ID - infrared light Face ID is Apple's latest move to make security and authentication as convenient as possible. Touch ID is active, requiring that you physically touch a sensor; Face ID is passive, requiring only that you glance at the phone. Fingerprint technology and facial recognition is used by lots of companies, not just Apple and not just in healthcare. However no other company has combined facial recognition with accessing medical records and smartphones for example. The combination of all three is what gives Apple a competitive advantage in healthcare. Face ID has set the new standard in remote authentication, identification and registration. The key first step in the patient journey, allowing access to digital health services. Apple has done what Apple does best, removed a lot of friction for patients/consumers and made a traditionally offline, time consuming and confusing process fast, convenient and easy. Apple could in theory take this one step further and match the photo/image stored on a government issued document like a driving licence or passport and "match" it against the image stored on the iPhone X using facial recognition. Payers and providers would then have another level of assurance that the patient/consumer accessing health data was the same person, another advantage in the world of healthcare data protection and information governance. Inside the notch at the top of the new iPhone X is the TrueDepth camera and sensors. This camera projects over 30,000 dots of light onto your face. The dots are invisible to your eyes. But you can see them through an infrared camera. The iPhone X's camera analyzes the dots of light on your face and compares it to the image made when Face ID was set up. If they match, the phone unlocks. Apple's Face ID system uses Apple's Machine Learning algorithms and a "Neural engine" hardware component built into the A11 processor to analyze and recognize your face. This includes keeping up to date with changing appearances, such as when you're growing a beard or wearing sunglasses. (The infrared light can see through those sunglasses to detect your gaze, and the system will still recognize you if enough data points match.) 3) Apple Watch non-invasive glucose monitoring solution - spectroscopy? It is widely rumoured that Apple is working on sensors that non-invasively and continuously monitor blood sugar levels. For example CNBC recently reported that Apple hired a team of around 200 PhDs as part of its effort on this front. The method by which Apple could potentially non-invasively monitor blood sugar levels is believed by many to be the application of light and spectroscopy. First envisioned by Michael Feld, the late MIT professor of physics and former director of the Spectroscopy Laboratory, the technique uses Raman spectroscopy, a method that identifies chemical compounds based on the frequency of vibrations of the bonds holding the molecule together. The technique can reveal glucose levels by simply scanning a patient’s arm or finger with near-infrared light, eliminating the need to draw blood. Researchers in the Spectroscopy Lab have been developing this technology for about 15 years. One of the major obstacles they have faced is that near-infrared light penetrates only about half a millimeter below the skin, so it measures the amount of glucose in the fluid that bathes skin cells (known as interstitial fluid), not the amount in the blood. To overcome this, the team came up with an algorithm that relates the two concentrations, allowing them to predict blood glucose levels from the glucose concentration in interstitial fluid. 4) Future applications of light by Apple in Healthcare - UV Light for Skin Disorders? Doctors use UV light to treat patients with vitamin D deficiency and other kinds of skin disorders. Light therapy and phototherapy treatments involve the use of specific wavelengths of light to treat many medical conditions including mood disorders; skin disorders such as psoriasis, eczema, vitiligo, and acne; sleep disorders; wound healing; and photodynamic therapy (PDT). "we have big plans in healthcare, which go beyond wellness apps and tools ... we can make a 'significant contribution' in healthcare" Could we see Apple make a "significant contribution to healthcare" by moving into the world of delivering care instead of just monitoring it ? In 3 to 5 years time will patients be able to use an Apple device to treat vitamin D deficiency and other kinds of skin disorders? 5) Future applications of light by Apple in Healthcare - Full Spectrum Light for SAD? Seasonal Affective Disorder (SAD) occurs during winter when people are exposed to fewer hours of natural sunlight. Symptoms of this condition include anxiety, fatigue, depression, overeating, weight gain and oversleeping. Using full-spectrum lights as light boxes or special bulbs and lamps can help reduce the negative symptoms of SAD. In 3 to 5 years time will patients be able to use an Apple device to treat Seasonal Affective Disorder? Could Apple apply the design and application of sound waves to the design and application of light waves? 6) Future applications of light by Apple in Healthcare - Vital Signs Apple's patent application #20170354332 filed in August 2017 talks about collecting health data which may include: a blood pressure index, a blood hydration, a body fat content, an oxygen saturation, a pulse rate, a perfusion index, an electrocardiogram, a photoplethysmogram, and/or any other such health data. The patent application shows us how they want to take the iPhone to the next level for health as it relates to allow users to measure their vitals. "Apple's invention covers systems, apparatuses, and methods related to an iPhone (iPad, Apple Watch etc) that computes health data. The device may include a camera, an ambient light sensor, and a proximity sensor. The electronic device may use one or more of the camera and the proximity sensor to emit light into a body part of a user (such as a finger, and ear, and so on) touching a surface of the electronic device. The electronic device may use one or more of the camera, the ambient light sensor, and the proximity sensor to receive at least part of the emitted light reflected by the body part of the user. The electronic device may compute health data of the user based upon sensor data regarding the received light. In this way, the health data of the user may be detected utilizing an electronic device including a camera, ambient light sensor, and proximity sensor without making the user obtain access to a dedicated fitness and/or wellness device." To conclude, Apple are clearly applying the laws of physics and developing new ways to use light in order to not only monitor and collect patient data (Enabling Care), but also to potentially offer treatment for medical conditions (Delivering Care) across their range of devices. Sources: https://newatlas.com/non-invasive-blood-glucose-test/16001/ http://gadgetsandwearables.com/2017/05/15/apple-watch-smart-bands/ https://support.apple.com/en-gb/HT204666 https://www.computerworld.com/article/3235140/apple-ios/what-is-face-id-apples-new-facial-recognition-tech-explained.html https://www.livestrong.com/article/29862-use-full-spectrum-light-sad/ http://www.patentlyapple.com/patently-apple/2017/12/apple-patent-reveals-a-future-iphone-being-able-to-scan-your-finger-and-measure-a-series-of-health-vitals.html Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://www.healthcare.digital HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk

Exec Summary The clinical workflow automation market is expected to continue to grow rapidly in the next 12 months, driven by a number of factors, including: The increasing complexity of healthcare delivery: Healthcare delivery is becoming increasingly complex, with more providers and organizations involved in the care of each patient. This complexity can lead to errors and inefficiencies. The rising cost of healthcare: The cost of healthcare is rising, and healthcare organizations are under pressure to find ways to reduce costs. Clinical workflow automation can help healthcare organisations reduce costs by automating tasks and streamlining processes. The increasing adoption of electronic health records (EHRs): EHRs are becoming increasingly common in healthcare organizations. EHRs can provide a centralised repository for patient data, which can help to improve the efficiency of clinical workflows. As a result of these factors, healthcare organizations are increasingly investing in clinical workflow automation solutions. This is driving demand for clinical workflow automation solutions, which is in turn driving M&A activity in the clinical workflow automation space. Some of the specific areas of clinical workflow automation that we expect to see the most M&A activity in the next 12 months include: Patient scheduling and registration: Patient scheduling and registration is a complex and time-consuming process that can be automated using clinical workflow automation solutions. Clinical documentation: Clinical documentation is another complex and time-consuming process that can be automated using clinical workflow automation solutions. Order entry and fulfilment: Order entry and fulfilment is a critical process in the healthcare system that can be automated using clinical workflow automation solutions. Medication management: Medication management is another critical process in the healthcare system that can be automated using clinical workflow automation solutions. Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://www.healthcare.digital HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk What exactly is clinical workflow automation? Clinical workflow automation is the use of technology to automate the tasks and processes involved in providing patient care. This can include tasks such as: Patient scheduling and registration Clinical documentation Order entry and fulfilment Medication management Laboratory and imaging orders Referral management Patient education and engagement Clinical workflow automation can help healthcare organisations to improve efficiency, reduce costs, and improve patient outcomes. For example, clinical workflow automation can help to reduce the time it takes to schedule a patient appointment, improve the accuracy of clinical documentation, and reduce the number of medication errors. Clinical workflow automation can be implemented using a variety of technologies, including electronic health records (EHRs), clinical decision support systems (CDSSs), and robotic process automation (RPA). EHRs can be used to automate tasks such as patient scheduling, order entry, and clinical documentation. CDSSs can be used to automate tasks such as drug interaction checking and clinical guideline compliance. RPA can be used to automate repetitive tasks such as data entry and order processing. Clinical workflow automation is a rapidly growing field, and there are a number of vendors that offer solutions for automating different aspects of clinical workflow. Healthcare organisations are increasingly adopting clinical workflow automation solutions to improve efficiency, reduce costs, and improve patient outcomes. Here are some examples of how clinical workflow automation is being used in healthcare today: A hospital might use a clinical workflow automation solution to automate the process of scheduling patients for appointments. This would involve the system automatically checking the patient's availability and the availability of the relevant healthcare providers. The system would then book the appointment and send the patient a confirmation message. A clinic might use a clinical workflow automation solution to automate the process of documenting patient encounters. The system would record the patient's symptoms, medical history, and physical examination findings. The system would then generate a clinical note that could be reviewed by the healthcare provider and the patient. A pharmacy might use a clinical workflow automation solution to automate the process of dispensing medications. The system would check the patient's medication history for any potential drug interactions. The system would then dispense the medication to the patient and provide them with instructions on how to take it. Clinical workflow automation has the potential to revolutionise the way that healthcare is delivered. By automating tasks and processes, clinical workflow automation can help healthcare organisations to improve efficiency, reduce costs, and improve patient outcomes. Key trends in the clinical workflow automation M&A market Some of the key trends that we expect to see in the clinical workflow automation M&A market in the next 12 months include: Continued consolidation of the market: We expect to see continued consolidation of the clinical workflow automation market, as larger companies acquire smaller companies with specialised expertise in specific areas of clinical workflow automation. Increased investment from private equity firms: We expect to see increased investment from private equity firms in the clinical workflow automation market. Private equity firms are attracted to the clinical workflow automation market because of its high growth potential and the fact that it is a fragmented market with many opportunities for consolidation. Increased focus on emerging technologies: We expect to see an increased focus on emerging technologies, such as artificial intelligence (AI) and machine learning (ML), in the clinical workflow automation M&A market. Healthcare organisations are increasingly looking for solutions and services that can help them automate tasks and streamline processes using these emerging technologies. Increased focus on artificial intelligence (AI): We expect to see an increased focus on AI in the clinical workflow automation M&A market. AI is being used to develop new and innovative clinical workflow automation solutions that can help healthcare organisations to improve efficiency and reduce costs. Increased focus on cloud-based solutions: We expect to see an increased focus on cloud-based clinical workflow automation solutions in the next 12 months. Cloud-based solutions offer a number of advantages over on-premises solutions, such as scalability, flexibility, and ease of use. Increased focus on interoperability: We expect to see an increased focus on interoperability in the clinical workflow automation M&A market in the next 12 months. Interoperability is the ability of different clinical workflow automation systems to communicate with each other. This is important because it allows healthcare organizations to create a more seamless and efficient clinical workflow. Overall, the clinical workflow automation M&A market is expected to remain active in the next 12 months, driven by the increasing complexity of healthcare delivery, the rising cost of healthcare, the increasing adoption of EHRs, and the growing demand from healthcare organisations for clinical workflow automation solutions. Final Thoughts Clinical workflow automation is the use of technology to automate the tasks and processes involved in providing patient care. It is a rapidly growing field, and there are a number of vendors that offer solutions for automating different aspects of clinical workflow. The future of clinical workflow automation is very bright. As technology continues to evolve, we can expect to see even more innovative and effective solutions emerge. Some of the key trends that we expect to see in the future of clinical workflow automation include: Increased use of artificial intelligence (AI) and machine learning (ML): AI and ML are already being used in clinical workflow automation to automate tasks such as clinical decision support and medication management. In the future, we can expect to see even more widespread use of AI and ML in clinical workflow automation. For example, AI and ML could be used to develop automated systems that can diagnose diseases, develop treatment plans, and monitor patients' progress. Increased focus on patient engagement: Clinical workflow automation can be used to improve patient engagement by providing patients with access to their own health information and by automating tasks such as appointment scheduling and medication reminders. In the future, we can expect to see even more clinical workflow automation solutions that are designed to improve patient engagement. Greater integration with other healthcare systems: Clinical workflow automation solutions are becoming increasingly integrated with other healthcare systems, such as electronic health records (EHRs) and patient portals. This integration is helping to create a more seamless and efficient healthcare experience for both patients and providers. Overall, the future of clinical workflow automation is very promising. As technology continues to evolve, we can expect to see even more innovative and effective solutions emerge that can help healthcare organizations to improve efficiency, reduce costs, and improve patient outcomes. Here are some specific examples of how clinical workflow automation might be used in the future: AI-powered chatbots could be used to triage patients and provide them with basic medical advice. ML could be used to develop personalised treatment plans for patients. RPA could be used to automate tasks such as data entry and order processing. Clinical workflow automation could be integrated with wearable devices to collect patient data and monitor their health. Clinical workflow automation has the potential to revolutionize the way that healthcare is delivered. By automating tasks and processes, clinical workflow automation can help healthcare organisations to improve efficiency, reduce costs, and improve patient outcomes. Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://www.healthcare.digital HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk

Exec Summary: Chief Artificial Intelligence Officers (CAIOs) are a new but increasingly important role in healthcare. As AI technology becomes more integrated into medical practices, healthcare organisations are looking for leaders to develop strategy and implementation, effectively communicate the benefits and risks of AI to all stakeholders and oversee the development and use of AI to ensure it is fair, unbiased, and adheres to patient privacy regulation. There are strong arguments to be made that now is the time for Chief AI Officers (CAIOs) in healthcare to take centre stage. Here's why: Rapid AI Adoption: The use of AI in healthcare is growing rapidly. Hospitals and healthcare systems are increasingly implementing AI tools for tasks like medical imaging analysis, drug discovery, and even robot-assisted surgery. With this rapid adoption, there's a need for dedicated leadership to guide responsible and strategic implementation. Strategic Advantage: A CAIO can help a healthcare organization gain a competitive edge by strategically utilising AI to improve patient care, optimise processes, and potentially reduce costs. They can identify areas where AI can have the most significant impact and ensure these projects are aligned with the organisation's overall goals. Ethical Considerations: AI in healthcare raises important ethical concerns around fairness, bias, and data privacy.A CAIO with expertise in both AI and healthcare can champion responsible AI development and ensure patient data is protected. While the role is still new, some leading healthcare institutions have already appointed CAIOs, suggesting it's becoming a crucial position. Chief AI Officers (CAIOs) in healthcare are a new position showing promising early successes. Here are a couple of key areas: Establishing AI Governance Frameworks: One of the crucial initial wins for CAIOs has been setting up frameworks for governing AI use. This includes creating clear guidelines for selecting and implementing AI projects, ensuring ethical considerations are addressed, and managing risks associated with the technology. Examples include Dr. Chornenky's work at UC Davis Health, where he implemented a successful governance framework that helped accelerate safe and responsible AI adoption. Developing Foundational AI Models: CAIOs are also leading the development of core AI models that can be integrated into existing workflows. These models focus on improving accuracy, efficiency, and consistency in areas like medical imaging analysis. For instance, Parminder Bhatia, CAIO at GE Healthcare, points to the SonoSAMTrack model, which aids in ultrasound imaging precision. These early successes highlight the value CAIOs bring by: Streamlining AI Adoption: By establishing clear guidelines and frameworks, CAIOs remove roadblocks and accelerate the safe and effective use of AI in healthcare settings. Enhancing Patient Care: Foundational AI models developed under CAIO leadership have the potential to directly improve patient care by increasing accuracy in diagnostics and other areas. It's important to note that the field is still young, and the long-term impact of CAIOs is yet to be fully realised. However, these early successes provide a promising outlook for the role and its potential to revolutionise healthcare with the responsible use of AI. Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://www.healthcare.digital HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk Chief Artificial Intelligence Officers (CAIOs) Chief Artificial Intelligence Officers (CAIOs) are a new but increasingly important role in healthcare. As AI technology becomes more integrated into medical practices, healthcare organisations are looking for leaders to: Develop Strategy and Implementation: CAIOs define how AI will be used within the organisation, prioritising projects and managing investments in AI technologies. Ensure Ethical Use: They oversee the development and use of AI to ensure it is fair, unbiased, and adheres to patient privacy regulations. Lead and Collaborate: CAIOs need a blend of medical and technical expertise to bridge the gap between data scientists and medical professionals. They collaborate across departments to ensure AI integration is smooth and effective. A Chief AI Officer (CAIO) is an executive-level position responsible for overseeing all aspects of Artificial Intelligence (AI) within an organization. It's a relatively new role, but becoming increasingly important as AI becomes more prevalent across industries. Here's a breakdown of a CAIO's key duties: Strategic Leadership: Defining AI Strategy: CAIOs develop a comprehensive strategy for how AI will be used throughout the organisation. This involves identifying areas where AI can add value, prioritising projects, and managing investments. Leading Implementation: They oversee the implementation of AI initiatives, ensuring projects are completed on time and within budget. Ethical Considerations: Ensuring Fairness and Bias Mitigation: CAIOs play a crucial role in ensuring AI is used ethically and responsibly. They develop and implement procedures to mitigate bias in AI algorithms and ensure fair treatment for all. Data Privacy and Security: They oversee compliance with data privacy regulations and ensure patient data is protected when using AI in healthcare settings. Collaboration and Communication: Bridging the Gap: CAIOs typically possess a blend of technical expertise in AI and a strong understanding of the organisation's domain. This allows them to bridge the gap between data scientists and other departments, facilitating smooth AI integration. Communication and Transparency: They effectively communicate the benefits and risks of AI to all stakeholders, including leadership, employees, and potentially the public. Overall, a CAIO is a visionary leader who ensures AI is leveraged effectively and ethically to achieve an organisation's goals. The future of Chief AI Officers in healthcare The future of Chief AI Officers (CAIOs) in healthcare appears bright, with their roles likely to evolve and expand as AI becomes even more ingrained in the industry. Here are some potential areas of growth: Focus on Interoperability and Integration: As the number of AI tools used in healthcare grows, CAIOs will play a crucial role in ensuring they work seamlessly together. This will involve creating standards for data exchange and promoting the development of interoperable AI platforms. Proactive Exploration and Innovation: Beyond foundational models, CAIOs will likely move towards exploring cutting-edge AI applications in areas like personalized medicine, drug development, and even robotic surgery. They'll be responsible for identifying promising new technologies and guiding their implementation. Addressing Equity and Accessibility: A crucial aspect will be ensuring that AI advancements benefit all patients equally. CAIOs will need to address issues of bias in algorithms and work towards developing AI solutions that are accessible to everyone, regardless of location or socioeconomic background. Building Public Trust and Transparency: As AI plays a more prominent role in healthcare decisions, maintaining public trust will be essential. CAIOs will be responsible for communicating the benefits and limitations of AI to the public and ensuring transparency in how AI is used. Here are some additional thoughts on the future of CAIOs: Evolving Skillset: The ideal CAIO skillset may change over time. While a blend of medical and technical expertise remains important, future CAIOs may also need strong leadership and communication skills to navigate complex ethical considerations and build trust with the public. Potential for Specialization: As the field matures, there's a possibility for specialization within the CAIO role. For instance, there could be CAIOs focused specifically on clinical AI applications or data privacy in AI healthcare use. Overall, the future of CAIOs in healthcare is likely to be one of continued growth and increasing responsibility. They will play a pivotal role in ensuring AI is used ethically, effectively, and equitably to revolutionise healthcare delivery and improve patient outcomes. Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://www.healthcare.digital HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk

Exec Summary The average multiples in HealthTech M&A deals in 2023 have declined compared to 2022, reflecting a more cautious approach by investors in the face of broader economic challenges. As of November 2023, the average enterprise value (EV) to sales multiple is 4.5x, down from 5.6x in 2022. The average EV to EBITDA multiple is 11.0x, down from 12.5x in 2022. Here's a breakdown of average multiples for different types of HealthTech companies in 2023: Telehealth companies: 5.5x Wellness companies: 4.0x Drug discovery companies: 7.0x Medical device companies: 5.0x Healthcare IT companies: 3.5x It's important to note that these are just averages, and the actual multiples for individual deals can vary significantly depending on the specific company, its growth prospects, and the competitive landscape. Several factors have contributed to the decline in HealthTech valuations in 2023: The overall economic slowdown: Investors are becoming more cautious about risk as the global economy slows down. The war in Ukraine: The war has created uncertainty and volatility in the markets, making investors less willing to take on additional risk. Rising interest rates: Rising interest rates make it more expensive for companies to borrow money, which can put pressure on their valuations. Regulatory scrutiny: The healthcare industry is subject to a lot of regulatory scrutiny, which can make it more difficult for companies to get deals done. Despite these challenges, the HealthTech M&A market is still expected to be active in 2023. Investors are still interested in investing in innovative HealthTech companies with the potential to disrupt the industry and improve patient care. However, valuations are likely to remain more subdued than they were in 2022. Here are some of the key trends to watch in the HealthTech M&A market in 2023: Focus on digital health: The growing adoption of digital health solutions by patients and providers is creating opportunities for consolidation. M&A to drive growth: Companies are looking to M&A to expand their product offerings, reach new markets, and gain access to new technologies. Strategic partnerships: Companies are forming partnerships to pool resources and expertise to address common challenges. The HealthTech M&A market is still evolving, but it is clear that there are significant opportunities for growth in this sector. Investors who are willing to take on some risk can potentially earn attractive returns by investing in the right companies. Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies HealthTech M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb Healthcare Technology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://lnkd.in/ezyUh5i HealthTech M&A transactions HealthTech M&A transactions can vary significantly in terms of size, nature, and market conditions. The multiples, or valuation metrics, used in these transactions are typically based on factors such as revenue, earnings, or users/subscribers, and can differ based on the company's stage of development, growth prospects, market position, and other relevant factors. Revenue Multiples: One commonly used metric is the revenue multiple, which measures the value of a company relative to its revenue. In HealthTech, revenue multiples can range widely depending on factors such as the company's growth rate, profitability, and competitive landscape. In the past, revenue multiples for HealthTech companies have ranged from 1x to 10x or more, with some highly valued companies commanding even higher multiples. Earnings Multiples: Another metric used in M&A transactions is the earnings multiple, which compares a company's valuation to its earnings (e.g., EBITDA - Earnings Before Interest, Taxes, Depreciation, and Amortization). Earnings multiples for HealthTech companies can vary based on factors such as profitability, growth potential, and industry trends. The range of earnings multiples in the HealthTech sector has historically been broad, spanning from single-digit multiples to higher double-digit or triple-digit multiples for high-growth, high-margin companies. User/Subscriber Multiples: In some cases, HealthTech companies with user-focused business models, such as telemedicine or digital health platforms, may be valued based on the number of users or subscribers they have acquired. Valuations based on these metrics can vary significantly depending on the size of the user base, user engagement, revenue per user, and other factors. While there isn't a fixed average multiple for user/subscriber-based valuations in HealthTech M&A, they can range from a few dollars per user to several hundred or even thousands of dollars per user, depending on the company's unique circumstances. Key trends driving strategic healthtech acquisitions: Here are some of the specific trends that are driving strategic healthtech acquisitions in today's market: The increasing demand for digital health solutions: The aging population and the growing prevalence of chronic diseases are driving the demand for digital health solutions. This is creating opportunities for healthtech companies that offer products and services that can improve the quality of care and reduce costs. The rise of artificial intelligence and machine learning: Artificial intelligence and machine learning are rapidly transforming the healthcare industry. These technologies are being used to develop new diagnostic tools, improve the efficiency of clinical workflows, and personalize treatment plans. The growing focus on preventive care: The healthcare industry is shifting its focus from reactive care to preventive care. This is creating opportunities for healthtech companies that offer products and services that can help people stay healthy. The increasing regulatory scrutiny: The healthcare industry is heavily regulated. This can make it difficult for healthtech companies to bring new products and services to market. However, it also creates opportunities for companies that can help healthcare organizations comply with regulations. Overall, the strategic healthtech acquisition market is very active. There are a number of factors driving this activity, including the increasing demand for digital health solutions, the rise of artificial intelligence and machine learning, the growing focus on preventive care, and the increasing regulatory scrutiny. Key priorities for strategic healthtech acquirers: The key priorities for strategic healthtech acquirers are: Growth: Strategic acquirers are looking for companies that can help them grow their businesses. This could mean acquiring companies that operate in new markets, offer new products or services, or have a strong customer base. Innovation: Strategic acquirers are also looking for companies that are innovative and can help them stay ahead of the competition. This could mean acquiring companies that are developing new technologies or have a strong track record of innovation. Market share: Strategic acquirers may also be looking to acquire companies that will give them a larger market share. This could be in a specific market or in the overall healthtech market. Competitive advantage: Strategic acquirers may also be looking to acquire companies that will give them a competitive advantage. This could be through access to new technologies, markets, or customers. Revenue: Strategic acquirers may also be looking to acquire companies that will generate additional revenue. This could be through the sale of products or services, or through the expansion of the acquirer's existing business. Profitability: Strategic acquirers may also be looking to acquire companies that are profitable. This could mean acquiring companies that have a strong track record of profitability or that have the potential to become profitable in the future. Exit strategy: Strategic acquirers may also have an exit strategy in mind, such as taking the acquired company public or selling it to another company. This will affect the type of company they are looking to acquire and the price they are willing to pay. The Future of HealthTech M&A The future of HealthTech M&A is likely to be shaped by several key trends: Rising Healthcare Costs and Pressure on Payers: Healthcare costs are rising at an alarming rate, putting pressure on payers, such as insurance companies and government programs. This is driving a demand for M&A activity that can help to improve efficiency and reduce costs. Technological Innovation: The healthcare industry is undergoing a period of rapid technological innovation, with the emergence of new technologies such as artificial intelligence, robotics, and genomics. This is creating opportunities for M&A activity that can help companies to acquire new technologies and capabilities. Changing Consumer Expectations: Consumers are becoming more informed and demanding about their healthcare experiences. They are increasingly looking for personalized, convenient, and affordable care. This is driving a demand for M&A activity that can help companies to meet these evolving consumer expectations. Global Expansion: The healthcare industry is becoming increasingly globalized, with companies expanding into new markets to reach a wider patient base. This is creating opportunities for M&A activity that can help companies to enter new markets and gain access to new technologies and talent. Regulatory Landscape: The regulatory landscape for healthcare M&A is complex and constantly evolving. Companies need to carefully consider the regulatory implications of any acquisition before proceeding. Here are some specific examples of how these trends are likely to shape the future of HealthTech M&A: We will see more deals between payers and providers: Payers are looking to acquire providers to gain more control over the healthcare system and improve their ability to manage costs. Providers are looking to acquire payers to gain access to new patient populations and improve their financial stability. We will see more deals between technology companies and healthcare companies: Technology companies are looking to acquire healthcare companies to gain access to new markets and new data sources. Healthcare companies are looking to acquire technology companies to improve their ability to collect, analyse, and use data to improve patient care. We will see more deals between healthcare companies and consumer-facing companies: Healthcare companies are looking to acquire consumer-facing companies to improve their ability to reach and engage with patients. Consumer-facing companies are looking to acquire healthcare companies to gain access to new data and insights into the healthcare industry. Overall, the future of HealthTech M&A is bright. The industry is undergoing a period of rapid change and innovation, and M&A is playing a key role in driving this transformation. As these trends continue to develop, we can expect to see even more M&A activity in the healthcare sector in the years to come. Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies HealthTech M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb Healthcare Technology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://lnkd.in/ezyUh5i